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1. Summary 
 
The majority of regulatory T cells (Tregs) are believed to be of thymic origin. It has 
been hypothesized that this may result from unique intrathymic environmental cues, 
possibly requiring a dedicated antigen presenting cell (APC). However, T cell intrinsic 
developmental regulation of the susceptibility to Treg differentiation remains a 
mutually non-exclusive scenario.  
We found that upon exposure of monoclonal T cells of sequential developmental 
stages to a thymic microenvironment expressing cognate antigen, the efficiency of 
Treg induction inversely correlated with progressive maturation. This inclination of 
immature thymocytes towards Treg differentiation was even seen in an APC-free in 
vitro system providing only TCR stimulation and IL-2. In support of quantitative but 
not qualitative features of external cues being critical, thymic epithelial cells as well 
as different thymic dendritic cell (DC) -subtypes efficiently induced Treg development 
of immature thymocytes, albeit at strikingly different optimal doses of cognate 
antigen. We propose that the intrinsically high predisposition of immature thymocytes 
to Treg development may contribute to the predominantly thymic origin of the Treg 
repertoire. The underlying instructive stimulus, however, does not require unique 
features of a dedicated APC and can be delivered by hematopoietic as well as 
epithelial thymic stromal cells. 
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2. Zusammenfassung 
 
Ein Großteil der regulatorischen T Zellen (Treg) der Maus ist thymischen Ursprungs. 
Erklärungsmodelle dafür beinhalten unter anderem Thymus spezifische Zell-
extrinsische Signale, möglicherweise in einer durch spezialisierte Antigen 
präsentierende Zellen (APC) geschaffenen Nische. Zusätzlich oder alternativ dazu 
könnten T-Zell-intrinsische Faktoren die Entwicklung von regulatorischen T Zellen im 
Thymus beeinflussen.  
Im Rahmen dieser Arbeit wurden monoklonale T Zellen unterschiedlicher 
Entwicklungsstadien in Thymi transferiert, die das spezifische Antigen für diese T 
Zellen exprimieren. Die Effizienz, mit der Zellen sich in Treg entwickelten, korrelierte 
dabei invers mit dem Reifegrad der transferierten Zellen. Diese verstärkte Neigung 
unreifer T Zellen in regulatorische T Zellen zu differenzieren konnte in einem APC-
freien System, das nur einen T-Rezeptor-Stimulus und Interleukin-2 beinhaltet, 
bestätigt werden. Weiters konnte gezeigt werden, dass sowohl Thymus Epithelzellen, 
als auch unterschiedliche Typen von thymischen Dendritischen Zellen die 
Entwicklung von Treg aus unreifen Thymozyten induzieren, sofern optimale Antigen 
Konzentrationen vorherrschten. Dies deutet darauf hin, dass die Quantität und nicht  
die Qualität T-Zell-extrinsischer Signale entscheidend für die intrathymische 
Entwicklung von Treg ist.   
Zusammenfassend  deuten die in dieser Studie vorgestellten Resultate darauf hin, 
dass der intrathymische Ursprung eines Großteils der Treg das Resultat einer 
verstärkten Prädisposition unreifer Thymozyten ist, in Treg zu differenzieren. Die dafür 
notwendigen extrinsischen Signale können dabei sowohl von hämatopoietischen als 
auch epithelialen APC geliefert werden.  
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3. Introduction 
3.1. Thymus organogenesis 
 
The thymus is the primary lymphoid organ providing the microenvironment for the 
development of the T cell arm of the adaptive immune system. In evolutionary terms 
the appearance of a thymus is closely linked to the development of antigen receptors 
based on random recombination events of variable (V), diversity (D), and joining (J) 
DNA segments, resulting in the generation of an enormously diverse T cell receptor 
(TCR) repertoire. Thymic structures probably co-evolved with the enzymatic 
machinery that allowed T lymphocytes to acquire a somatically rearranged VDJ-TCR. 
Consequently thymic structures are only found in species that apply VDJ-
recombination to diversify their antigen receptors, that is jawed vertebrates (1, 2).  
The number and anatomical location of these thymic structures varies considerably 
among different species with mice and humans carrying a thoracic thymus consisting 
of bilobular or multilobular lobes, respectively. Moreover, cervical thymi have been 
described in both mice (3, 4) and humans (5, 6) but their incidence in humans is 
somewhat unclear. Cervical thymi are frequently found in mice, albeit at markedly 
different frequencies in variable inbred mouse strains analyzed (3). To what extend 
these cervical thymi contribute to the development of the T cell pool is currently 
unclear.  
The thymus is characterized by an enormous cellular turnover as a result of the 
constant development and emigration or death of T cells. Due to the highly 
migratorial nature of developing thymocytes and the large contribution of these cells 
to the overall thymic cellularity the thymus is not a solid organ. Nevertheless, it 
contains a scaffold of stromal cells providing the microenvironment for T 
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lymphopoiesis. The combination of these framework and thymocytes of various 
developmental stages allows for the morphological separation of the thymus into 
cortical and medullary regions that serve distinct functions during early and late 
thymocytes development, respectively. 
The adult thymus is comprised of cells of various developmental origins (see Figure 1 
for major thymic cell types and their developmental origin). About 98% of these cells 
are of hematopoietic origin and are characterized by the expression of the cell 
surface molecule CD45. The vast majority of these cells are thymocytes of different 
developmental stages. Additionally, hematopoietic antigen presenting cell types like 
macrophages, B cells and various dendritic cell (DC) subtypes can be found. Non-
hematopoietic cells of the thymus segregate into epithelial and mesenchymal cells. 
Although constituting a minor fraction of thymic cellularity, thymic epithelial cells 
(TEC) are indispensable for the establishment of thymic microenvironments that are 
essential for developing thymocytes.  Interaction of thymocytes with these highly 
specialized TEC is required at multiple stages of their development and is of 
fundamental importance in the acquisition of a functional and self-tolerant T cell 
compartment. Thymic mesenchymal cells constitute the third major cell type that can 
be found in the thymus. Mesenchymal cells include fibroblasts, various endothelial 
cells and cells forming the thymic capsule and septae. 
Thymic structures originate from the third pharyngeal pouch region of the foregut at 
around day 10.5 (E10.5) of mouse embryonic development (2). Given the importance 
of epithelial cells in the formation of thymic compartments, the developmental origin 
of epithelial cell precursors that can be found in the “thymic anlage” is of fundamental 
interest. In early models it was proposed that cells of ectodermal and endodermal 
origin both give rise to TEC progenitors that would subsequently differentiate into 
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cortical or medullary epithelia cells (cTEC and mTEC), respectively. To address the 
germ layer origin of thymic epithelial cells, grafting experiments in birds were 
conducted. In these elegant experiments quail embryonic endoderm grafts were 
transplanted into chicken embryos and were found to give rise to both cTEC and 
mTEC and suggested a single germ layer origin (endodermal) of the thymic 
epithelium (7). More recently the question regarding the germ layer origin of TEC was 
readdressed in the mouse. To this end a combination of elegant experiments 
involving dye labeling, embryo culture techniques and grafting of endoderm-only third 
pouch tissue was applied. Transplantation of endoderm-only third pouch tissue under 
the kidney capsule of athymic recipient mice led to the ectopic development of a fully 
functional thymus. These results provided further experimental proof for the single 
endodermal origin of the thymic epithelium (8, 9).  
The developmental origin of thymic mesenchymal cells is somewhat unclear. The 
Neural Crest (NC) was thought to provide a potential source of these cells during 
development. To study the contribution of NC-derived cells to the thymic 
mesenchyme NC-specific expression of Cre-recombinase combined with Cre-activity 
dependent reporters was applied to detect NC-derived cells in the developing or adult 
thymus (10, 11). While NC-derived cells were shown to significantly contribute to the 
thymic mesenchyme at early stages of thymus development (E13), these cells were 
confined to a cell population sandwiched between endothelial and epithelial cells 
lining the thymic vasculature in adult mice. Thus NC-derived thymic fibroblasts and 
cells forming the thymic capsule and thymic septae might be replenished with cells of 
as yet unknown origin during development (10). 
Irrespective of its cellular contribution to the thymus, the NC was shown to serve an 
additional, non-redundant function during thymus development. A lack of interaction 
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between mesenchymal cells and TEC (progenitors) was shown to result in severe 
thymic hypoplasia (12, 13). This conclusions were drawn based upon studies in birds 
were absence of interactions between the (cephalic) NC during embryonic 
development led to a severe size reduction of the thymus (12). Several signaling 
pathways were proposed to possibly contribute to the “nurturing” function of 
mesenchymal cells in this context (2) and especially signals involving fibroblast 
growth factor 10 (FGF-10) and its specific receptor FGFR2-IIIb on epithelial cells 
seemed to be required for the development of a mature functional thymus since 
ablation of either of these molecules leads to the development of severe thymic 
hypoplasia, possibly due to a lack of proliferative stimulation provided by 
mesenchymal cells (13).  
 
 
 
Figure 1 – Developmental origin of major cell types in the thymus. The thymus can 
be divided into hematopoietic cells (CD45+) and non-hematopoietic stromal cells 
(CD45-) that can be further subdivided into epithelial (Keratin+) and mesenchymal 
cells (Keratin-). The origin of mesenchymal cells appears to be heterogeneous and 
the cellular contribution of NC-derived cells changes considerably during ontogeny 
[figure structure adapted from (2)]. 
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Prior to hematopoietic colonization of the thymus at around E12 the thymus is not 
compartmentalized into medullary and cortical structures. At these developmental 
stages TEC are thought to exhibit a precursor characteristics that eventually allow 
them to differentiate into mTEC and cTEC seen at later stages of thymus 
development. Distinct stages of TEC development are characterized by the 
expression of certain keratin family members. While mature TEC comprise keratin-
8+/keratin-5- cTEC and keratin-8-/keratin-5+ mTEC, the majority of TEC express both 
of these keratins at the precursor stage (14, 15). On a population level these 
epithelial precursors give rise to both cTEC and mTEC. Whether, on a single cell 
level, these cells could give rise to both cTEC and/or mTEC and thereby constitute a 
pool of bi-potent precursors was recently addressed in two studies either applying 
single cell transfer of E12 thymic epithelial cells or a lineage tracing approach (16, 
17). Both studies came to the conclusion that both cTEC and mTEC can develop 
from a population of bi-potent precursor cells. Although these data brought 
unequivocal proof for the existence of such bi-potent precursors, purification of these 
cells based upon the expression of cell surface markers is still not feasible.  
Morphological separation of medullary and cortical thymic compartments is 
characterized by a gradual reduction of the keratin-8+/keratin-5+ pool of epithelial 
precursors and the differentiation of these cells into cTEC and mTEC. This 
developmental progression was proposed to be dependent upon hematopoietic 
colonization of the thymus and to require “crosstalk” between epithelial (precursor) 
cells and thymocytes. Evidence in favor of the importance of such interactions came 
from mouse models that exhibited a developmental block at early thymocyte stages 
that severely impaired the formation of a properly compartmentalized thymus (18, 
19). Apart from these (as yet unidentified) signals affecting the developmental 
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progression of epithelial precursors, members of the tumor necrosis factor (TNF) 
receptor family have been shown to impinge on the development of TEC and the 
thymic architecture, mainly affecting the formation of a functional mTEC 
compartment. mTEC can be separated into mTEClow (MHCII-CD80-) and mTEChigh 
(MHCII+CD80+), whereby the latter population is of special importance due to its 
ability to both promiscuously express otherwise tissue restricted antigens and to 
directly present them to developing thymocytes. Ablation of the Lymphotoxin-β 
receptor, receptor activator of NF-κB (RANK), and CD40 caused the development of 
“disorganized” medullary regions or affected the cellularity of these mTEC 
subpopulations (20-24). The importance of these receptors was substantiated by the 
analysis of animals deficient or impaired in their downstream signaling components 
TNF-receptor associated factor 6 (TRAF6), NF-κB-inducing kinase (NIK), IκB kinase 
α (IKKα), and the NF-κB subunit RelB. 
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Figure 2 – Signaling pathways involved in the formation of TEC. Various sources 
provide proliferative and/or differentiation stimuli to TEC during thymus ontogeny. 
The figure depicts pathways known to affect the development of the indicated TEC 
stages. Question marks indicate a lack of knowledge either about pathways involved 
or the precise function of known stimuli in TEC development. Additionally, knockout 
or transgenic models used to study the role of the respective pathways are depicted 
(see text for references). LTi , Lymphoid Tissue inducer cell. 
 
Defective signaling led to even more severe phenotypes concerning mTEC cellularity 
and the medullary architecture than observed in single-receptor deficient mice, 
indicating redundancies amongst members of the TNF receptor family and possibly 
other pathways activating these downstream signaling molecules (25-29). The 
general importance of these signaling pathways is also highlighted by defective 
tolerance induction leading to the development of autoimmunity manifestations, 
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probably as a result of the impaired formation of medullary structures [see Figure 2 
for a schematic overview of (crosstalk) pathways involved in TEC development].  
 
3.2. T cell progenitors and T cell lineage commitment  
 
T cell development and maturation is, as opposed to the development of other blood 
cell types, strictly dependent upon the thymus. Since self-renewing potential is limited 
or absent in thymus resident progenitor populations (30) sustained T cell 
development requires continuous input of blood borne progenitor cells (31). Entry of 
T cell progenitors into the thymus was shown to be a gated phenomenon (32). It was 
proposed that the thymic microenvironment provides a limited number of niches for 
incoming progenitors and that mobilization of progenitor cells from the bone marrow 
and importation of this rare population of blood borne cells might be co-regulated 
(33). Additionally, the number of bone marrow resident T cell progenitors is thought 
to be subject to periodic fluctuations (33). Whether the periodic development of T cell 
progenitors in the bone marrow and their subsequent release into the blood is 
affected by the depletion of progenitor cells in the thymus and regulated by feedback 
mechanisms is unclear to date (32-34).  
While studies on the developmental potential of different populations of bone marrow 
resident progenitor cell types have narrowed down the search for physiologically 
relevant precursors they did not allow for an assessment of the contribution of each 
of these populations to the development of the T cell compartment under 
physiological conditions. Most in vivo studies either used immune-deficient or 
irradiated recipient mice creating an artificial situation in terms of available niches in 
the thymus, homing capabilities of precursors and competition among these cells. A 
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prerequisite for a physiologically relevant T cell progenitor population would be its 
efficient and timed mobilization from the bone marrow combined with efficient homing 
of these cells to available intrathymic niches. Studies on the development of such 
progenitors and their mobilization are complicated by their low abundance, however. 
Extravasation of progenitors into the thymic microenvironment has been predicted to 
involve rolling along the vascular endothelium as a result of low affinity interactions, 
probably involving selectins and their interaction partners on the vascular 
endothelium, followed by integrin/chemokine mediated arrest and transmigration into 
the thymus. Thymic vascular structures rendering the extravasation of progenitors 
into the thymus possible according to the paradigm illustrated above have been 
indentified (11). To address the thymus tropism and mode of extravasation of 
different bone marrow derived progenitor populations immune-deficient animals were 
reconstituted with these populations and numbers of cells that homed to the thymus 
were assessed. In these studies a subset of common lymphoid progenitor cells 
termed CLP-2 was seen to show robust thymus homing capabilities. Moreover, P-
selectin/PSGL-1, CCR9/CCL25, and α4 or β2 integrins and their counterreceptors 
ICAM-1 or VCAM-1 were suggested to be mechanistically involved in this process 
(35). Whether this represents a general mechanism applicable to all progenitors that 
show thymus tropism remains to be established. 
Thymus entry of T cell progenitors is thought to occur at the corticomedullary junction 
(CMJ) (36) and the earliest intrathymic progenitors that can be found in the thymus 
have been termed early T cell progenitors (ETP) and reside within the CD4-/lowCD3-
CD8-CD25-CD44+ (DN1) population of cells (37). ETP are characterized by the 
expression of CD117 and have been found to be heterogeneous concerning the 
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expression of CCR9, Flt3 and CD24. This heterogeneity has been suggested to 
represent developmental transitions within this precursor population (38).  
Thymocyte progenitors and the least mature thymocytes reside in an area termed 
perimedullary cortex (PMC) for up to 10 days. During this period extensive cellular 
expansion (~1000 fold) accompanied by the asynchronous utilization of cells to 
replenish the T cell pool takes place. During the stages preceding the recombination 
of T cell receptor (TCR) genes developing thymocytes commit to the T cell lineage in 
a manner that is strictly dependent upon Notch1 signaling. Inducible inactivation of 
either Notch1 or the downstream transcription factor recombination signal binding 
protein-J (RBP-J) led to a developmental block in intrathymic T cell development at 
or before the DN1 stage of development (39, 40). This phenotype was recapitulated 
in mice lacking Delta-like 4 (Dll4) on thymic epithelial cells. Hence Notch1 and Dll4 
interactions play a crucial and non-redundant role in T cell development (41-43). 
Furthermore, Notch signaling strength affects lineage commitment, whereby 
abrogation of B cell development required only low levels of Notch signals, whereas 
intermediate levels are necessary to shift the balance towards T cells at the expense 
of NK lineage potential (44). The precise role of Notch1-Dll4 interactions and 
downstream events that eventually trigger the initiation of the T cell lineage 
developmental program are not well established but Notch signaling has been shown 
to both affect lineage commitment and maintenance of the metabolic state of T cells, 
possibly serving different roles at distinct developmental stages of T cell development 
(44, 45).  
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3.3.  Thymic stromal microenvironments and thymocyte development 
 
Thymocyte development proceeds along well defined stages characterized by the 
expression of cell surface molecules (see Figure 3) during their migration through 
different stromal compartments of the thymus. These stromal compartments are not 
separated by rigid structures but are defined by the localization of thymocytes at 
distinct developmental stages. Due to their complex migratorial pattern thymocytes of 
different developmental stages can co-localize, leading to an extensive overlap of 
thymic compartments as defined above. However, the combination of thymocyte 
extrinsic signals and cellular interaction partners combined with stage specific 
changes in the integration of the very same environmental cues allows for the 
definition of distinct signaling microenvironments (46). 
Several zones have been described with the first one, the PMC being situated 
immediately adjacent to the CMJ. This region provides the appropriate 
microenvironment for DN1 cells. As stated above cells can reside in this area for up 
to 10 days (47) and undergo massive proliferative expansion during this period. DN1 
cells do not synchronously leave the PMC but rather segregate into cells that reside 
in the PMC, possibly providing a (limited) source of progenitors,  and cells that 
progress to the next developmental stage (47). This might account for the 
observation that T cell development, as opposed to homing of T cell progenitors, is a 
continuous process. A detailed mechanistic understanding of factors that mediate 
retention and proliferation of DN1 cells or trigger their release from the PMC is still 
missing. 
Migration of cells out of the PMC coincides with their transition into the DN2 
(CD44+CD25-) developmental stage. DN2 cells are found in the inner half of the outer 
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cortex and their average residence time in this area is only about 2 days (47). Area 
specific events include proliferative expansion and (further) commitment to the T cell 
lineage (46). Migration to these cortical regions is thought to involve interactions of 
DN2 cells with thymic stromal cells via integrins and vascular cell adhesion molecule-
1 (VCAM-1).  VCAM-1+ cells constitute a subset of thymic stromal cells in the cortex 
(48) and are thought to form a lattice along which DN2 cells migrate into the outer 
cortical regions. DN2 cells have been found to remain in close contact with VCAM-1+ 
cells during this migration, probably via α4β1 integrin interactions (49), and it has 
indeed been suggested that this reticular lattice might provide a limited number of 
niches for developing thymocytes to continue their development and subsequently 
enter the outer cortical regions (46). Additionally CXCR4 expressed on DN2 cells and 
its ligand CXCL12 expressed on cortical stromal cells were shown to be essential for 
the migration of DN2 cells from the PMC into the outer cortical regions (50-52). 
Further maturation of cells coincides with migration into the outer cortical regions and 
developmental progression to the DN3 (CD44-CD25+) stage.  Migration of cells to the 
outer cortical regions/capsule was shown to critically depend upon CCR9 and its 
ligand CCL25 since absence or premature expression of CCR9 affects migration of 
DN3 cells into the subcapsular zone of the cortex or exit from this region, respectively 
(53, 54). Cells reside for about two days in the subcapsular zone, undergoing 
proliferative expansion and irreversible commitment to the T cell lineage (55). A key 
process at this stage is the induction of TCRβ-locus recombination. Recombination 
events critically depend upon the expression of RAG genes and IL-7 signaling has 
been shown to induce expression of RAG1 and RAG2 at stages preceding TCRβ-
locus recombination. Another function of IL-7 signaling in T cell receptor locus 
recombination might be the induction of locus accessibility by as yet ill defined means 
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(56, 57). During their residence in the subcapsular zone of the thymus, DN3 cells 
complete recombination of the TCRβ locus. This stage marks the first checkpoint 
during T cell development termed β-selection. Only successful recombination of one 
of the TCRβ-loci allows for the progression of cells to the CD4/8 double positive (DP) 
stage. Successful rearrangement is marked by the expression of the pre-TCR, a 
dimer of the TCRβ-chain and a pre-TCRα chain. Pre-TCR signaling is thought to 
occur in a ligand independent way (58) and successful rearrangement of one TCRβ-
chain and signaling by the pre-TCR excludes recombination of the other locus (59).  
 
 
 
Figure 3 – Stages of thymocyte development preceding maturation in the thymic 
medulla.  Early stages of thymocyte development can be defined by the expression 
of the indicated cell surface molecules. Early T cell progenitors (ETP) are a 
heterogeneous population of cells that eventually give rise to DN1 cells. Thymocyte 
development preceding the expression of a pre-TCR is characterized by strong 
proliferative expansion and Notch1/Dll4 dependent T cell lineage commitment. 
Subsequent selection events or proliferative expansion are critically dependent upon 
the expression of a (pre-)TCR.    
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Another consequence of successful rearrangement is the acquisition of a blast like 
morphology and a dramatic increase in proliferative activity in the subcapsular region 
that generates the bulk cellularity of the thymus (60). Once DN3 cells pass β-
selection they rapidly upregulate CD4 and CD8 expression. Cells expressing low 
levels of CD4 and CD8 have been referred to as DN4 (CD44-CD25-) cells or pre-DP 
cells. The most critical events during the pre-DP stage are the initiation of TCRα 
locus recombination and the reversion of their migration polarity. The extrinsic cues 
responsible for the inward migration of pre-DP and DP cells are only poorly 
understood. 
Interaction with cortical epithelial cells is essential after recombination of the TCRα 
locus for the next checkpoint/maturation step to occur. This checkpoint is termed 
positive selection and is characterized by interactions between the TCR and peptide-
major histocompatibility complex (pMHC) molecules that allow for the selection of 
cells bearing successfully rearranged TCRs that recognize self ligands with low 
affinity (61). Cells that do not express T cell receptors allowing for positive selection 
undergo apoptosis in a process termed “death by neglect”.  
Another essential process happening at the DP stage of development is the 
commitment to either the CD4 or CD8 T cell lineage. Although significant progress 
has been made in terms of understanding the molecular basis of CD4/CD8 lineage 
commitment (62-65) the initial steps leading to the induction of lineage specification 
factors remain unclear. Several models have been proposed either relying on 
stochastic events terminating the expression of one or the other co-receptor or 
instructive models suggesting mutual inhibition of co-receptor expression, depending 
upon either MHC class I or MHC class II molecules driving positive selection. In both 
cases lineage commitment only requires TCR-pMHC interaction and does not 
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necessarily involve additional stromal cues. Another model proposed a role for IL-7 
signaling in CD8 lineage commitment. In this “co-receptor reversal” model TCR-
triggering initially terminates expression of the CD8 co-receptor. If loss of CD8 
expression abolishes TCR-signaling, IL-7 signaling initiates re-expression of CD8 
and commitment to the cytotoxic T cell lineage. Conversely, sustained signaling in 
the absence of CD8 expression will inhibit IL-7 signal transduction and deviate cells 
into the CD4 lineage (66). 
Once cells underwent positive selection and possibly lineage commitment their 
migration becomes polarized and is directed towards the thymic medulla. This 
directed migration is thought to occur in a CCR7 specific manner. Abrogation of 
CCR7 guided migration leads to a failure of positively selected thymocytes to enter 
the thymic medulla and consequently to an accumulation of mature thymocytes in the 
cortex (67). Full maturation of thymocytes does not depend upon migration of 
positively selected thymocytes into the medulla. The acquisition of a fully self-tolerant 
T cell repertoire is, however, tightly linked to the interaction of developing thymocytes 
with medullary antigen presenting cells. Consequently, “ectopic” maturation of 
thymocytes in the cortex leads to a failure to establish a self tolerant T cell 
compartment (67). Selection events in the thymic medulla are driven by cognate 
TCR-pMHC interactions that lead to either the elimination of auto reactive cells 
(termed negative selection/deletion) or the induction of regulatory T cells (Treg) with 
both mechanisms being crucial for the maintenance of a self-tolerant immune state. 
As opposed to the thymic cortex the medulla contains significant numbers of dendritic 
cells (DC) and furthermore a population of medullary thymic epithelial cells (mTEC) 
that is specialized in expressing a wide range of otherwise tissue restricted antigens, 
a phenomenon termed “promiscuous gene expression”. Presentation of this wide 
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range of antigens by mTEC themselves or “distribution” of these antigens to DC-
subpopulations allows medullary antigen presenting cells (APC) to mirror the 
peripheral self in order to tolerize the developing T cell compartment (68).  
 
3.4. Immunological Tolerance – historical overview 
 
With the acquisition of somatic recombination as a means to diversify the scope of 
antigens that cells of the adaptive immune system can recognize, a fundamental 
problem arose in terms of preventing the immune system from attacking self-
determinants (69). Already in 1957 Burnet suggested, in his seminal paper on “clonal 
selection” that each lymphocyte only expresses one antigen-receptor specificity and 
that cells recognizing self-determinants could be subject to tolerance induction by 
functional impairment or clonal deletion (70). At that time it was proposed that all 
immune-competent cells were produced during embryonic development. Antigen 
encounter during an early developmental period (embryonic) would then lead to the 
deletion of cells, since all antigens available at this time would be self derived. This 
elegant model centered on the ontogeny of the individual as the key factor in the 
acquisition of immunological tolerance. Experimental proof for this theoretical 
framework was provided by transplantation experiments done by Medawar and co-
workers. Transplantation of skin grafts from semi-allogenic donors onto newborn 
mice, i.e. mice that still lacked a fully immune-competent immunological state, was 
shown to result in tolerance to these grafts if it was accompanied by 
embryonic/neonatal transfer of hematopoietic cells of donor haplotype. A basic 
corollary of Burnet’s and Medawar’s theory on “actively acquired tolerance” is that 
grafts transplanted “early enough” should be tolerated by the recipient’s immune 
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system due to the ability to recognize the graft as self later on. Yet transplants were 
only tolerated with high incidence if embryos/neonates were pre-inoculated with 
hematopoietic cells.  This tolerization protocol did not work if the inoculum was of 
non-hematopoietic origin. Results leading to similar conclusions were also derived 
from transplantation experiments in chicken. “Learning” self obviously required 
hematopoietic cells of donor origin in this setup. Back then these transplantation 
experiments were nevertheless interpreted as unequivocal proof for the existence of 
a window of time during ontogeny during which tolerance could be imposed onto or 
learned by developing immune cells (71).  
The concept of a “developmental window” accounting for the observations seen in 
chicken and mouse transplantation experiments was at odds with observations 
suggesting that lymphocytes do not only arise during embryonic development but 
throughout adult life. Even if the embryonic and perinatal period represented a 
specialized environment for the acquisition of a tolerant state, tolerance induction 
would, due to the constant production of lymphocytes, have to be efficient later on to 
allow for the maintenance of a tolerant state. Already in 1959 Lederberg suggested 
that it might be the ontogeny of the lymphocyte, not the ontogeny of the whole 
organism, that represents the critical determinant in tolerance induction. He proposed 
that the outcome of antigen encounter would critically depend upon the maturity of 
the lymphocyte; the defining characteristics of “maturity” were unclear, however (72).  
Apart from the “timing” problem another fundamental issue was the availability of 
self-determinants in the process of tolerance induction. Developing lymphocytes 
would have to encounter all possible self determinants to be rendered anergic or to 
be deleted to sustain immunological tolerance. Thus, crucial questions remained 
open at the time. 
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About three decades after the postulation of “developmental tolerance”, the question 
of self-non-self-discrimination was re-addressed using quail/chicken interspecies 
transplantation experiments. In these elegant experiments embryonic quail tissue 
was transplanted onto chicken embryos to test for the induction of tolerance. 
According to Burnets postulates the transplanted tissues should have been tolerated 
due to the immune system recognizing the graft as self during this early stage of 
development. Surprisingly enough the opposite was the case. As soon as the 
transplanted chickens acquired full immunological competence, donor derived 
tissues were acutely rejected (73). Thus a key postulate of the “developmental 
tolerance” hypothesis was proven wrong.  
Another key experiment, published in 1987 showed that co-transplantation of a donor 
derived thymic anlage conferred tolerance to transplanted tissues. However, 
tolerance induction was not the result of the deletion of “autoreactive” cells as 
alloreactivity of T cells in transplanted animals was still evident (74). Accordingly both 
a reinterpretation of previous results and the incorporation of a phenomenon termed 
“dominant tolerance” into the concept of immunological tolerance seemed to be 
required.  
Transplantation experiments in the quail/chicken model suffered from the lack of 
available tools to narrow down the population of cells responsible for this “dominant 
tolerance”. However, in 1990 similar conclusions were also drawn from analogous 
experiments in nude mice and it was additionally shown, that “dominant tolerance” 
was mediated by “regulatory” T cells (75, 76). The concept of regulatory T cells, or 
“suppressor T cells”, was already proposed in the seventies (77), but the failure to 
exactly define a population of cells that exert regulatory or immune modulatory 
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functions within the T cell compartment combined with a lack of mechanisms 
responsible for these effects hampered progression in this field.  
The availability of appropriate tools and a series of seminal publications led to the 
identification of a subset of T cells that was potent in suppressing various 
manifestations of autoimmunity. The presumable loss of a regulatory T cell 
population and the induction of massive autoimmunity seen by early thymectomy 
combined with the restoration of a tolerant state in various models of autoimmunity 
by the transfer of CD45RClow or CD45RAlow T cell subsets allowed for the 
identification of T cell populations strongly enriched for regulatory activity (78-80). 
This work culminated in the identification of CD4+ T cells expressing high constitutive 
levels of CD25, the high affinity chain of the IL-2 receptor complex, as being the 
population of cells responsible for these regulatory effects (81). Subsequently 
significant progress has been made in establishing the crucial importance of these 
cells and thereby “dominant tolerance” by the identification of the lineage specific 
transcription factor Forkhead box p3 (Foxp3) that unequivocally identifies cells that 
have been imprinted with the transcriptional program of regulatory T cells (82-88). 
 
3.5. Experimental proof and mechanistic basis of negative selection 
 
Seminal studies during the last decades have proven clonal deletion as being a 
crucial mechanism of immunological tolerance. Although this was suggested 
relatively early in the field, experimental proof appeared to be difficult to obtain. It was 
suggested that T cells educated in an allogenic thymus were depleted of alloreactive 
MHC-specific cytotoxic T lymphocyte precursors [reviewed in (89)]. However, these 
studies suffered from a lack of experimental tools to allow for the detection of T cells 
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that would be lost upon antigen encounter during the process of tolerance induction. 
A definitive experimental proof for clonal deletion would necessitate following 
individual TCR-specificities during their intrathymic development, i.e. finding 
specificities/individual TCRs that initially arose but were deleted later on. Two 
experimental approaches were highly instrumental in solving this issue. First, a 
monoclonal antibody that recognized Vβ17a+ TCRs was generated (90). This 
antibody allowed for the detection of a fraction of T cells and to follow this population 
during its intrathymic development. T cells expressing a Vβ17a+ TCR were shown to 
be deleted in a mouse strain specific manner (91). Initially, strain specific expression 
of I-E MHCII molecules was thought to lead to this deletion. Later on, the “ligands” for 
this TCRs were shown to be mouse mammary tumor superantigens-8,-9 (92, 93). 
Importantly, early developmental stages of Vβ17a+ cells (DP) were unaffected 
whereas cell numbers of mature thymocytes and peripheral T cells were markedly 
reduced. Second, TCR-transgenic mice were created that allowed for following a 
single TCR-specificity along its intrathymic development. Co-expression of the 
cognate ligand of the respective specificity led to a strong reduction in cell numbers 
of thymocytes bearing the transgenic TCR [reviewed in (94)]. Thus decades after the 
initial proposal of deletion as being an essential means to establish tolerance to self-
constituents experimental proof was available corroborating this central paradigm of 
immunological tolerance. A detailed characterization of spatial and temporal 
requirements allowing for the efficient deletion of autoreactive cells remained 
challenging, however.  
Negative selection requires cognate TCR-pMHC interactions. Thus the earliest stage 
of thymocyte development that can be negatively selected is the (late) DP stage. In 
addition to TCR-pMHC interactions co-stimulatory molecules have been 
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demonstrated to impinge on the efficiency of negative selection. Both CD28/B7 
interactions and CD40/CD40L interactions have been shown to affect clonal deletion 
(95, 96). Whether different co-stimulatory molecules trigger downstream pathways 
specifically involved in negative selection or whether they act to amplify TCR 
signaling pathways and thereby increase negative selection is somewhat unclear. 
The purported redundancy of co-stimulatory pathways increasing negative selection 
probably favors the latter interpretation (97).  
TCR-proximal signaling events are similar in positive and negative selection, 
nevertheless some molecules seem to be uniquely involved in negative selection 
(94). TCR signaling involves a large number of proteins that form an immunological 
synapse and a signalosome integrating stimulatory and co-stimulatory cues that 
result from (cognate) TCR-pMCH interactions (98). Key molecules downstream of 
TCR signaling involve amongst others members of the mitogen activated protein 
kinase (MAPK) family. It has been suggested that the activation and 
compartmentalization of different members of this family of kinases defines the 
outcome of TCR signaling in thymocyte selection processes.  Negative selection has 
been shown to involve the activation of jun N-terminal kinases (JNK), p38, and 
extracellular signal-regulated kinase (ERK) whereas (weak) positive selecting signals 
involve only activation of ERK, albeit with different kinetics and sub cellular 
localization (94, 99) of ERK. Accordingly, interference with upstream components of 
these pathways, like the adaptor protein Grb2 that is involved in activation of the Ras 
pathway, ultimately leading to the activation of the JNK/p38 kinases, reduces 
negative selection in TCR-transgenic models and in CD3-crosslinking-mediated 
induction of apoptosis (100, 101). Additional evidence for the importance of JNK/p38 
signaling in negative selection came from the identification and characterization of 
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misshapen NIKs-related kinase (MINK). MINK is highly expressed in DP thymocytes 
and its knockdown was shown to result in an inhibition of TCR induced JNK 
activation and impaired negative selection in superantigen and TCR-transgenic 
models of deletion (102). Although this provides another striking piece of evidence for 
the importance of these MAPK pathway(s) in negative selection, the precise nature of 
molecular interactions/signaling events linking TCR signaling with JNK activation is 
currently unknown. It has been suggested that MINK is linked to the TCR complex 
via the adaptor protein Nck and provides a scaffold for MAPKKKs and MAPKKs 
subsequently activating JNK. Consistent with this model the kinase activity of MINK 
is not required for its function in activating the JNK pathway (102, 103).  
The ultimate outcome of signaling events leading to the deletion of autoreactive T 
cells is the induction of programmed cell death and several molecules were revealed 
to play a non- redundant role in this process. In principle apoptosis can be triggered 
via cell surface receptors of the tumor necrosis factor receptor (TNFR) family and Fas 
and via activation of pro-apoptotic members of the Bcl-2 family of proteins. Induction 
of apoptosis in thymocytes was shown to depend upon Fas ligation when high 
antigen doses were applied (104). Likewise, inhibition of multiple TNFR pathways by 
virtue of a dominant negative construct blocking apoptosis inducing signaling did not 
impair negative selection (105). The second pathway, involving members of the Bcl-2 
family, induces apoptosis by triggering the release of mitochondrial cytochrome-C 
that binds the apoptosis protease activation factor-1 (APAF-1) which subsequently 
leads to the initiation of cleavage of caspases ultimately leading to cell death. 
Deletion of Apaf-1 does not significantly impair thymocyte negative selection, 
however, implying alternative pathways inducing the activation of the caspase 
cascade in the absence of Apaf-1 (106). Prominent members of the Bcl-2 family 
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involved in inducing apoptosis are Bim, Bax, and Bak, whereby Bax and Bak are 
thought to act downstream of Bim. Deletion of Bim or combined deletion of Bax and 
Bak results in defective negative selection in multiple model systems studied (107, 
108). The combined action of Bim, Bax, and Bak is thought to lead to mitochondrial 
instability and subsequently to apoptosis (109). Another important molecule in 
negative selection is the nuclear receptor 77 (Nur77). Activation of T cells via the 
TCR leads to strong transcriptional activation of the Nur77 gene that can by itself 
trigger apoptosis. Likewise impairment of Nur77 function by virtue of overexpression 
of a dominant negative form of Nur77 leads to defective negative selection (110). The 
precise mechanisms whereby TCR signaling affects transcription or posttranslational 
modification of these molecules and thereby ultimately triggers apoptosis is unknown 
(109).  
As stated above negative selection can already be initiated at the DP stage and 
experimental evidence indicates that developmental progression gradually reduces 
the susceptibility of thymocytes to undergo apoptosis as a result of antigenic 
stimulation (104).  How (a combination of) the above mentioned pathways or 
alternatively a lack of survival signals co-operate to establish the “window of 
sensitivity” to negative selection during the ontogeny of lymphocytes that has been 
proposed decades ago remains to be shown in detail. 
 
3.6. Thymic development of Foxp3+ regulatory T cells 
 
The experiments of Nicole Le Dourain and colleagues have firmly established a role 
of dominant tolerance in immune homeostasis. The identification of regulatory T cells 
several years later and the establishment of Foxp3 as the lineage defining 
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transcription factor of regulatory T cells have allowed for the examination of 
fundamental aspects of regulatory T cell induction and development.  
Loss of regulatory activity within the T cell compartment by ablation of Foxp3 lead to 
the development of massive autoimmunity and reconstitution of these mice with Treg  
was shown to be sufficient to abrogate this pathologic manifestations (111). Since 
these autoimmune manifestations were arguably driven by the recognition of self-
constituents the fundamental question arose as to how the regulatory T cell 
repertoire inhibiting autoimmunity relates to the partly autoreactive repertoire of naïve 
T cells. Regulatory T cells bear multiple hallmarks of activated conventional T cells, 
such as expression of the cell surface molecules CD25, PD-1, GITR, and CTLA-4  
indicative of (constant?) antigen encounter (112). This surface marker expression 
profile is already intrathymically imprinted on Treg, implying a possible role for TCR-
pMHC interactions during the development of Treg. Evidence for the importance of 
TCR derived signals during the development of Treg came from observations made in 
TCR transgenic systems. While polyclonal T cells segregate into conventional T cells 
and Treg at a fairly constant ratio, TCR transgenic T cells that lack expression of 
endogenously rearranged TCR chains do not give rise to Treg (113-115).  This picture 
changes if the cognate ligand for the respective transgenic TCR is expressed 
intrathymically. Antigen encounter by developing thymocytes can lead to the 
appearance of a robust fraction of Foxp3+ cells in these models (115-117). To study 
the potential autoreactivity of the Treg repertoire in a “physiological” setting, TCR 
repertoires of conventional and Treg cells of the thymus and the periphery of TCRβ 
transgenic mice were compared, allowing for studies on a diverse, yet limited 
repertoire of TCR specificities. These studies suggested that conventional and Treg 
TCRs showed only a limited overlap in repertoire. Retroviral transduction of T cells 
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with Treg TCRs and subsequent transfer of these cells into lymphopenic and 
nonlymphopenic hosts conferred the ability to these cells to rapidly expand, indicative 
of cognate antigen encounter (118, 119). These data bolstered the hypothesis that 
autoreactivity is an essential hallmark of these cells and that it might also be involved 
in the induction of these cells in the thymus.  
A critical event during the development of regulatory T cells is the induction of Foxp3 
expression. Although Foxp3 was shown to amplify already established features of 
intrathymically arising Treg and to confer them with regulatory activity it appeared to 
be downstream of as yet ill defined events initially driving the commitment of these 
cells to the Treg lineage. Nevertheless Foxp3 is essential for the establishment and 
maintenance of the Treg transcriptional signature (120-123). Genetic ablation of 
components implicated in Treg biology combined with biochemical studies on the 
mechanistic basis of the regulation of Foxp3 gene expression allowed for the 
delineation of minimal requirements for Treg development in vitro. TCR stimulation 
combined with TGFβ and IL-2 signalling seemed to be sufficient to induce Treg from 
naïve precursors (124). Studies on the suppressive potency and most importantly 
stability of these so called adaptive Treg were contradictory, however (124-128). 
Additionally, genetic evidence indicated that intrathymic Treg induction followed 
fundamentally different rules since both ablation of IL-2/CD25 or TGFβRII in T cells 
did not lead to a drastic reduction in intrathymic numbers of Foxp3+ cells (129-131). 
Additionally, the need for CD28/B7 co-stimulation could be bypassed by the provision 
of IL-2 in vitro but was suggested to be required for the induction of Foxp3 
expression in vivo (132). The interpretation of these results is complicated by the 
involvement of IL-2 induced and CD28/B7 co-stimulatory pathways in both cellular 
survival and differentiation, however (133-136). 
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Recent studies have readdressed the importance of TGFβ signalling in natural Treg 
induction and came to different conclusions. Loss of TGFβ induced signals did 
indeed severely reduce the first wave of Foxp3+ cells arising at around day three 
after birth. This lack of Foxp3+ cells was then compensated for by massive 
proliferative expansion that critically depended upon IL-2 signalling (137). 
 
 
 
Figure 4 – Induction, differentiation and maintenance of Treg. Intrathymic 
development of Treg can be subdivided in an instructive phase and a phase of 
differentiation that is characterized by the expression of Foxp3 protein, demethylation 
of regulatory regions in the first intron of the Foxp3 gene (TSDR) and the acquisition 
of the Foxp3 dependent transcriptional program. Maintenance of a stable Treg 
phenotype requires continued expression of Foxp3, consequently factors that are 
involved in transcriptional regulation of Foxp3 expression have been shown to be 
involved in the maintenance of these cells. The figure depicts signaling pathways that 
have been proposed to be implicated in Treg development, whereby the earliest 
events remain ill defined. Based upon genetic evidence both cognate antigen 
encounter and intact TGFβ-signaling were proposed to play a prominent role. 
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Hence TGFβ appears to play a non-redundant role in intra- and extrathymic Treg 
induction whereas IL-2 signalling might be involved in differentiation and 
maintenance of these cells but is possibly not involved in Foxp3 “locus opening” or 
the earliest events of Treg lineage commitment. The precise molecular events 
allowing for initial transcription of Foxp3 are not yet clear. 
Differentiation of T cell lineages and expression of lineage specific cytokines was 
shown to coincide with massive epigenetic changes that allowed for stable lineage 
commitment (138, 139). While this aspect is still somewhat underexplored in Treg, 
stable expression of Foxp3 was shown to be accompanied by demethylation of an 
intronic region of the Foxp3 gene. This region was termed T cell specific 
demethylated region (TSDR) and did not show demethylation upon in vitro induction 
of Treg differentiation in mature naive T cells (126, 140, 141). Hence it was 
speculated, that the TSDR methylation status would be a feature distinguishing 
natural from adaptive Treg cells. Recent evidence indicates that demethylation can 
also occur in peripheral naïve cells in vivo, however (142). The mechanistic basis for 
demethylation, i.e. active demethylation versus “passive demethylation” as a 
consequence of lacking de novo methylation during cell cycling, is currently unclear.  
While essential aspects of the earliest events driving cells into the regulatory T cell 
lineage remain poorly defined, genetic and biochemical evidence allowed for the 
characterisation of a transcription factor network involved in the differentiation of Treg 
and maintenance of Foxp3 expression. Genetic studies have implicated TCR-, IL-2-, 
TGFβ- and Notch-derived signals as essential in this respect. Accordingly, 
biochemical characterisation of the Foxp3 promoter and intronic regulatory regions 
revealed binding sites for the TCR-signalling activated transcription factors SP1, 
AP1, NFAT and CREB/ATF. Additionally IL-2 induced STAT5, TGFβ induced SMAD3 
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and Notch induced RBP-J and Hes1 were shown to transcriptionally regulate Foxp3 
expression (140, 143). Thus significant progress has been made in unravelling 
essential aspects of Treg biology in terms of their differentiation and maintenance. A 
detailed picture of T cell intrinsic and T cell extrinsic factors and their effects during 
the “inductive” phase of Treg development is still missing. 
 
3.7. Thymic APC in tolerance induction 
 
As mentioned above thymocyte development can be separated into developmental 
stages preceding the expression of a TCR and late developmental stages that 
involve selection events that are based upon TCR-pMHC interactions and are critical 
for the induction of central tolerance. Multiple APC types are involved in this process 
and both qualitative/quantitative as well as spatio-temporal aspects of antigen 
presentation by these APC impinge on the outcome of cognate TCR-pMHC 
interactions.  
APC in the thymic cortex are mainly comprised of cTEC and a low number of DC. 
While providing essential cues for the positive selection of thymocytes cTEC were 
proposed to be inefficient in inducing negative selection (144, 145). Induction of Treg 
in the thymic cortex was also reported (146, 147), but in terms of total numbers of 
Foxp3+ cells that can be found in the thymus the contribution of these DP Treg to the 
total pool of Foxp3+ cells seems to be relatively low (147). Thus a separation of the 
thymus into cortical regions that are essential for positive selection and medullary 
regions that are essential for negative selection and the induction of dominant 
tolerance is, although obviously not absolute, an interesting scenario. This 
hypothesis on a division of labor between the major thymic compartments, that is 
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cortex and medulla, is not only bolstered by experiments addressing the principal 
potential of cTEC to mediate negative selection or dominant tolerance but also by the 
fact that “full” tolerance induction requires interaction of developing thymocytes with a 
broad diversity of self-ligands presented by medullary APC.  This requirement is met 
by medullary APC in two ways. First, the promiscuous expression of otherwise tissue 
restricted antigens by a subset of mTEC and their presentation by both mTEC and 
thymic DC allows for a considerable broadening of the scope of “self” that is 
presented to developing thymocytes (68) and second, medullary DC consist of both 
autochthonous DC and DC subpopulations that arise extrathymically and migrate into 
the thymus later on. These migratory populations of DC have been proposed to 
extend the pMHC diversity presented in the thymic medulla by importing peripheral 
antigens (148, 149).  
Negative selection has been primarily attributed to DC  due to the strongly increased  
frequency of mature thymocytes arising in thymi that lack MHCII expression on 
hematopoietic cells (150). As a consequence of a lack of experimental tools, the 
quantitative contribution of antigen presentation by mTEC to negative selection 
remains difficult to be addressed. Induction of Treg has been attributed to both mTEC 
(151) and DC (152), rendering the probability of a single APC type mediating 
induction of dominant tolerance low. Additionally, thymic DC show a considerable 
heterogeneity (153) and the contribution of different DC subtypes only begins to be 
unraveled.  
Deciphering the role of mTEC and different medullary DC in tolerance induction 
needs to take into account both the principal ability of these stromal APC to 
contribute to recessive and dominant tolerance induction and the contribution of each 
of these cell types to the highly diverse peptide ligandome that is presented within 
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the thymic medulla. Both of these aspects are technically challenging to address in 
vivo and certainly await further refinement.  
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4. Aim of the present study 
 
As stated above it is commonly accepted that the majority of natural Treg originate 
from intrathymic selection processes. Evidence that the polyclonal Treg population is 
enriched in autoreactive T cells (119, 154) and observations in TCR transgenic 
models have indicated that intrathymic self-antigen encounter molds the Treg 
repertoire. When and how this dedicated T cell lineage branches of from 
“mainstream” thymocyte development remains controversial. We and others have 
suggested that Treg arise at the CD4 single-positive (SP) stage through what may be 
called “altered negative selection” in the thymic medulla (116, 155). Other studies 
have proposed that Treg differentiation is the consequence of “altered positive 
selection” of CD4+CD8+ double-positive (DP) thymocytes located in the cortex (146, 
147, 156-158). Yet another model recently suggested that unknown factors trans-
condition the propensity of thymocytes to give rise to Treg even prior to positive 
selection (159). Importantly, any of these models would have to account for why 
developing Treg are not subject to clonal deletion. Thus, some investigators have 
suggested a stochastic/selective mode of Treg development, whereby thymocytes 
may randomly, i.e. in an at least initially antigen independent manner, commit to a 
developmental program that selectively protects developing Treg from clonal deletion 
(160, 161). Alternatively, largely unknown signals provided by dedicated niches, e.g. 
particular stromal cell types and/or cytokine and co-stimulatory milieus, may favor 
Treg development over clonal deletion (155, 162, 163). A variation of an instructive 
mode of Treg induction assumes a pivotal role of the avidity of self-antigen encounter 
(116, 164), thus bearing resemblance to classical models of positive selection. 
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Some of this controversy certainly arises from the fact that prospective identification 
of Treg precursors remains a significant experimental challenge. Foxp3-reporter mice 
unable to express the functional Foxp3 protein have been instrumental in delineating 
the role of Foxp3 in the control of late stage Treg differentiation and acquisition of full 
functional competence (120-122). However, because these studies position Foxp3 
function relatively far downstream in Treg development, they did not reveal the 
external cues or the molecular and phenotypic changes that coordinate Treg 
differentiation upstream of Foxp3. Significant progress in this regard was very 
recently achieved by the demonstration that the Foxp3−CD25+ subset of polyclonal 
CD4 SP thymocytes is highly enriched in Treg precursors (165). These cells appeared 
to represent the penultimate stage prior to Foxp3 expression, and acquisition of the 
“mature” Foxp3+ Treg phenotype required only IL-2 or IL-15, but was largely 
independent of TCR engagement. These findings support a two-step model, whereby 
Treg development segregates into a TCR-driven “instructive” and a cytokine-driven 
“consolidation” phase. It remained open, however, at which stage of thymocyte 
development and by which stromal cell type the “instructive” TCR signal can be 
delivered. Similarly, these studies did not reveal the temporal relation between TCR 
signal and the acquisition of a Foxp3+ Treg phenotype.  
For obvious reasons, these questions can essentially not be answered when 
studying the polyclonal T cell repertoire. Here, we used a previously described TCR 
transgenic model to circumvent these experimental limitations. In the TCR-HA × 
AIRE-HA model, thymocytes specific for the transgenic neo-self antigen influenza 
hemagglutinin (HA) efficiently differentiate into Treg cells due to intrathymic 
expression of cognate antigen under control of the Autoimmune Regulator (aire) 
gene locus (155). We first verified that the precursor/progeny relationships that have 
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been outlined in the two-step model of polyclonal Treg development also apply to the 
TCR-HA × AIRE-HA model. Using intrathymic transfer of post-positive selection 
thymocytes, we then asked whether Treg conversion by agonist encounter can be 
temporally dissociated from the CD4+CD8+ double-positive stage of thymocyte 
development, and defined the temporal relation between “instructive” lineage priming 
and the acquisition of a mature Treg phenotype. Furthermore, we aimed to reveal an 
eventual interrelation of a CD4 T cell’s maturation stage with its receptiveness for Treg 
lineage commitment. Finally, we used the TCR transgenic model to address whether 
Treg conversion of CD4 SP cells requires a dedicated antigen presenting cell. 
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5. Results  
5.1. Heterogeneity of TCR-HA+ CD4 SP cells in TCR-HA × AIRE-HA mice 
 
Polyclonal CD25+Foxp3− thymocytes have recently been shown to contain 
precursors of CD25+Foxp3+ cells (165). We first sought to ascertain that the critical 
hallmarks of this “two-step model of Treg differentiation” also apply to the TCR-HA × 
AIRE-HA model. 
Besides phenotypically and functionally mature CD25+Foxp3+ Treg cells, TCR-HA+ 
CD4 SP thymocytes from TCR-HA × AIRE-HA mice also contained Foxp3− cells. 
These could be subdivided into a CD25− and a CD25+ subpopulation, in the following 
referred to as pre-Treg 1 (PTR1) and PTR2, respectively (Figure 5A). Neither PTR1 
nor PTR2 displayed suppressive potential in vitro (data not shown).  
Compared to mature Treg, PTR2 cells expressed similarly elevated levels of the 
activation markers GITR, PD-1 and CD44, whereas CD69 was expressed at 
substantially higher levels on PTR2 cells (Figure 5). PTR1 cells could be further 
subdivided into GITR+ and GITR− cells. All PTR1 cells were highly positive for the 
early activation marker CD69, distinguishing them from truly “naïve” TCR-HA+ CD4 
SP thymocytes cells in TCR-HA single transgenic controls. 
Analysis of maturation markers revealed that CD25+Foxp3+TCR-HA+ cells were 
homogenously CD62Lhi. These cells also segregated into CD24hi and CD24lo as well 
as Qa-2hi and Qa-2int cells, respectively (Figure 6 A). PTR2 cells displayed a more 
immature phenotype (CD62Lint, CD24hi, Qa-2lo), and concerning these markers the 
surface phenotype of PTR1 cells closely resembled that of PTR2 cells. 
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Figure 5 - Characterization of CD4 SP thymocyte subpopulations of TCR-HA × AIRE-
HA. (A) Selection of Treg in TCR-HA × AIRE-HA mice. The plots depict stainings of CD4 SP 
of 5-week-old TCR-HA or TCR-HA × AIRE-HA mice for TCR-HA and CD25 expression 
(upper panel) or Foxp3-gfp and CD25 expression on gated TCR-HA+ CD4 SP cells (lower 
panel). Numbers indicate the average frequency (± s.d.) of cells within these areas. (n = 5 for 
TCR-HA mice, n = 35 for TCR-HA × AIRE-HA mice). (B) Activation marker expression of 
TCR-HA+ CD4 SP cells. The histograms show overlays of naïve TCR-HA+ cells and 
subpopulations of TCR-HA × AIRE-HA mice as outlined in the lower right panel of (A). Data 
are representative of 5 TCR-HA and 3 TCR-HA × AIRE-HA mice. 
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Figure 6 - Maturation marker expression and methylation state of CD4 SP 
subpopulations of TCR-HA × AIRE-HA mice. (A) The histogram shows overlays of naïve 
TCR-HA+ cells and subpopulations of TCR-HA × AIRE-HA mice (as outlined in Figure 1 A) 
stained for the indicated maturation markers. (B) Methylation state of the TSDR within the 
Foxp3 gene. The DNA-methylation pattern of CpG motifs within an evolutionary conserved 
intronic enhancer region of the Foxp3 gene in indicated subpopulations of TCR-HA+ CD4 SP 
of TCR-HA × AIRE-HA and TCR-HA mice is shown. Each box depicts the methylation-state 
of a single CpG motif according to the color code shown to the right. 
 
Demethylation of CpG motifs within a conserved region of the foxp3 locus upstream 
of exon-1 is a hallmark of natural Treg, and this T cell-specific demethylated region 
(TSDR) was found already to be mostly demethylated in developing Foxp3+ 
thymocytes (126). Reminiscent of these observations in polyclonal Treg, we found 
demethylation of about 60% of the CpG motifs in the TSDR of CD25+Foxp3+TCR-
HA+ cells (Figure 6 B). By contrast, neither PTR2 nor PTR1 cells showed evidence 
for DNA demethylation at these sites. 
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 Figure 7 - TCR-HA+ CD4 SP cells of TCR-HA × AIRE-HA mice show increased rates of 
proliferation and apoptosis and express varying levels of Foxp3 mRNA (A) Intracellular 
staining for the proliferation marker Ki67. The histogram (left) shows an overlay of 
representative stainings of subpopulations as defined in Figure 1 A. The bar-diagram (right) 
shows the average percentages (± s.d., n = 3) of Ki67+ cells within subpopulations (gating as 
indicated in the histogram overlay). (B) The diagram depicts the average percentage (± s.d., 
n = 3) of apoptotic cells within subpopulations as determined by staining for Annexin-V. (C) 
Foxp3 mRNA expression of sorted subpopulations was quantified by real time PCR and 
normalized to the expression level of CD25+Foxp3+ Treg. The average normalized 
expression (± s.d., n = 3) is shown. 
 
In contrast to CD25+Foxp3+TCR-HA+ cells, PTR1 and PTR2 cells contained a 
substantial fraction of cells staining positive for the proliferation marker Ki67 (Figure 7 
A). At the same time, the fraction of cells staining positive for the early apoptotic 
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marker Annexin-V was also elevated within PTR1 and PTR2 cells when compared to 
“mature” Treg of TCR-HA × AIRE-HA mice (Figure 7 B). 
The results so far indicated that essentially all Foxp3− subsets of TCR-HA × AIRE-HA 
mice contained antigen experienced cells. However, it remained open whether PTR1 
and PTR2 may represent or at least contain precursors of CD25+Foxp3+ cells, or 
whether these cells had committed to a cell fate other than Treg differentiation, e.g. 
abortive proliferation / negative selection. In favor of the former scenario, we detected 
elevated Foxp3 mRNA levels in GITR+ PTR1 cells and in PTR2 cells as compared to 
GITR− PTR1 or naïve CD4 SP cells of TCR-HA single transgenic animals (Figure 7 
C). Taken together, the phenotypic heterogeneity of TCR-HA+ CD4 SP cells in the 
TCR-HA × AIRE-HA model recapitulated the essential phenotypic transitions that 
have recently been established for polyclonal  Treg development, consistent with the 
idea that at least a fraction of PTR1 and PTR2 cells in TCR-HA × AIRE-HA mice 
were Treg precursors. 
 
5.2. Foxp3− CD4 SP cells from TCR-HA × AIRE-HA mice can differentiate into 
CD25+Foxp3+ cells in vivo 
 
In order to test eventual precursor/progeny relationships between the various subsets 
of TCR-HA+ thymocytes from TCR-HA × AIRE-HA mice, we isolated GITR− PTR1, 
GITR+ PTR1 and PTR2 cells (Figure 8 A) and transferred them intra-thymically (i.t.) 
into AIRE-HA recipients. On day four after transfer, most of the progeny of GITR− or 
GITR+ PTR1 cells had up-regulated CD25, i.e. resembled PTR2 cells, and a 
substantial fraction of the progeny of GITR+ PTR1 cells had indeed acquired a 
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CD25+Foxp3+ Treg phenotype (Figure 8 B, upper panel). Transition into the Treg 
compartment was most efficient for the progeny of PTR2 cells.  
 
 
Figure 8 - Foxp3− subpopulations of CD4 SP thymocytes contain Treg precursors 
Subsets of TCR-HA+ Foxp3-gfp− cells of TCR-HA × AIRE-HA CD45.1 mice were sorted 
based upon expression of GITR and CD25 (A). Numbers indicate the frequency of cells 
within sorting gates. 3 × 105 cells of each subpopulation were then transferred i.t. into AIRE-
HA or WT recipient mice. Mice were sacrificed after four days and thymocytes were analyzed 
for Foxp3-gfp and CD25 expression on CD45.1+ donor-type cells. Representative plots for 
each subset injected into either AIRE-HA or WT thymi are shown in (B). Numbers in plots 
indicate the average frequency (± s.d., n = 3) of Foxp3-gfp+ cells recovered. Data are 
representative of four independent experiments. (C, D) Polyclonal CD4 SP subsets of 
CD45.1 mice were sorted as depicted in (C) and indicated numbers were transferred into WT 
recipient mice. After four days CD45.1+ donor type cells were analyzed for Foxp3-gfp and 
CD25 expression. Representative plots for each subset are shown. Data are representative 
of two independent experiments. 
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These observations established that GITR+ PTR1 and PTR2 cells contained cells 
with Treg precursor potential that faithfully recapitulated the developmental potential of 
polyclonal thymocytes of the respective phenotype (Figure 8 C and D, and (165)). 
It remained unclear whether GITR+ PTR1 or PTR2 cells required continuous contact 
with agonist ligand in the host environment to realize their Treg potential. We therefore 
performed i.t. transfers into WT recipients (Figure 8 B, lower panel). Under these 
circumstances, the majority of GITR− PTR1 cells remained CD25−Foxp3−. By 
contrast, among the progeny of GITR+ PTR1 cells there was a considerable fraction 
of cells that had up-regulated Foxp3, indicative of antigen independent 
developmental progression towards a Treg identity. However, in contrast to the 
observations in antigen-expressing recipients, these Foxp3+ cells segregated into 
CD25+ and CD25− subpopulations, suggesting inefficient induction or loss of CD25 in 
the absence of continuous antigen encounter. Similarly, although the capacity of 
PTR2 cells to progress towards a “mature” Treg phenotype when deprived of continual 
stimulation by cognate antigen exceeded that of GITR+ PTR1 cells, this process was 
less efficient than in AIRE-HA recipients. 
Together, these data suggest a developmental progression in the order 
CD25−Foxp3−GITR− → CD25−Foxp3−GITR+ → CD25+Foxp3−GITR+, ultimately 
leading to the mature CD25+Foxp3+GITR+ Treg phenotype. Moreover, as early as at 
the CD25−Foxp3−GITR+ stage, some cells have undergone full commitment towards 
the Treg lineage, such that subsequent to this developmental stage, further TCR 
stimulation appears to be beneficial, but not absolutely required for differentiation 
towards a CD25+Foxp3+ phenotype. 
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5.3. Antigen driven commitment to the Treg lineage by “post-positive 
selection” CD4 SP thymocytes in vivo 
 
One critical feature distinguishing the “altered positive selection” and the “altered 
negative selection” model of Treg differentiation, i.e. the initiation of Treg induction in 
the cortex or the medulla, respectively, is the postulation of discrete developmental 
windows of opportunity at which Treg differentiation can be initiated. So far, our data 
indicated that the progression of CD4 SP thymocytes towards a “mature” Treg 
phenotype in the TCR-HA × AIRE-HA model partitioned into an antigen-dependent 
and an antigen–independent phase, very much in analogy to what has recently been 
described for polyclonal Treg development  (165). However, these observations did not 
reveal whether the instructive TCR stimulus itself can occur at the CD4 SP stage, or 
whether prior contact with cognate antigen concomitant to positive selection at the 
CD4+CD8+ stage might be an essential prerequisite. 
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Figure 9 - Naïve TCR-HA+ cells give rise to Treg after intrathymic injection into AIRE-
HA recipient mice (A) Experimental design. 5 × 105 CD4 SP cells from CD45.1 TCR-HA+ 
Rago/o Foxp3-gfp mice were intrathymically transferred into either WT or AIRE-HA recipient 
mice (CD45.2). (B) In WT recipients, transferred cells exhibited a stable Foxp3−CD25− 
phenotype. (C) Kinetics of intrathymic Treg development in AIRE-HA thymi. Injected cells 
were analyzed for Foxp3-gfp and CD25 expression at different time points as indicated 
above the plots. Numbers in quadrants indicate the percentage (± s.d., n = 3) of cells within 
the respective quadrant. (D) Emergence of CD25+Foxp3+ and CD25−Foxp3+ cells. The 
diagram depicts the average percentage (± s.d., n = 3) of CD25+Foxp3+ or CD25−Foxp3+ 
recovered from AIRE-HA recipient mice at the indicated time points. (E) Recovery of injected 
cells. The diagram shows the average absolute number (± s.d., n = 3) of cells recovered from 
intrathymically injected AIRE-HA or WT mice at the indicated time points. (F) Proliferation 
upon intrathymic antigen encounter. Pkh26 labeled cells were i.t. injected into either WT or 
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AIRE-HA recipient mice. The histogram shows an overlay of subpopulations recovered from 
AIRE-HA recipients and of CD25−Foxp3− cells recovered from WT recipient mice five days 
after i.t. injection. Data are representative of three independent experiments. 
 
In order to ask whether the initiation of Treg differentiation by cognate antigen can be 
developmentally dissociated from positive selection and CD4 lineage commitment, 
we i.t. transferred CD4 SP cells obtained from TCR-HA Foxp3gfp Rag2o/o mice 
(Figure 9 A). These cells were free of any Foxp3+ cells, and expectedly maintained a 
stable CD25−Foxp3− phenotype following injection into control WT recipients (Figure 
9 B). By contrast, intrathymic transfer into AIRE-HA recipients resulted in a swift and 
homogenous up-regulation of CD25 as early as twelve hours after injection (Figure 9 
C). On day two, about half of the cells had down-regulated CD25 again. Between 
days three and four, Foxp3+ cells appeared that segregated into CD25− and CD25+ 
cells. Foxp3+CD25− cells had essentially disappeared by day six, whereas the 
frequency of “mature” Foxp3+CD25+ cells reached a maximum between days four 
and five and remained relatively stable thereafter (Figure 9 D).  
A second TCR transgenic system was used to verify that these findings can be 
generalized. Indeed, i.t. transfer of OVA-specific CD4 SP cells from DO11.10 Rag2o/o 
Foxp3gfp mice into recipients expressing the DO11.10 epitope fused to HA driven by 
an mTEC-specific bacterial artificial chromosome (BAC) transgene (designated 
AIRE-HCO) (155) yielded results that closely resembled the findings in the TCR-HA 
system, both in terms of percentages of Foxp3+ cells recovered and the kinetics of 
their differentiation (Figure 10 A and B). Together, these findings clearly established 
that intrathymic Treg differentiation can efficiently be initiated in a manner that is fully 
dissociated from positive selection. 
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In the steady state thymus of TCR-HA × AIRE-HA mice, differentiation into the Treg 
lineage coincides with a substantial loss of TCR-HA+ cells (Figure 1 and (155)), 
indicating that Treg differentiation and negative selection are “competing” mechanisms 
of tolerance in this system. In order to address whether this scenario of concomitant 
Treg induction and clonal deletion also applies to the “acute” TCR-HA → AIRE-HA i.t. 
transfer setting, we determined the absolute number of donor type cells at various 
time points after i.t. injection. Up to two days after injection, the recovery of donor 
cells in AIRE-HA thymi was considerably lower as compared to WT controls, most 
likely indicating that indeed a substantial fraction of the injected cells are subject to 
clonal elimination as a consequence of antigen recognition (Figure 9 E). Whereas in 
control WT recipients the number of donor cells continually decreased over time, 
most likely as a result of thymic egress (166), in AIRE-HA recipients a sharp increase 
in cell numbers set in on day two. The absolute number of donor cells in AIRE-HA 
recipients reached a maximum around day 4 and was then followed by a gradual 
decline. These dynamic changes suggested proliferative expansion of at least a 
fraction of the injected cohort of cells. To address this issue, donor cells were labeled 
with the fluorescent dye pkh26. Five days after transfer, essentially all progeny of 
cells injected into AIRE-HA hosts displayed a reduced pkh26 fluorescence, whereas 
cells injected into control WT hosts expectedly remained pkh26 bright, i.e. did not 
cycle to any measurable extent (Figure 9 F).  
Of note, cells that had differentiated into Foxp3+CD25+ Treg in AIRE-HA thymi 
retained substantially more pkh26 dye than Foxp3−CD25+ or Foxp3−CD25− cells, 
indicative of a history of only limited proliferation. Consequently, the actual fraction of 
the starting population committing to a Treg fate is considerably underestimated when 
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assessed solely on the basis of the relative abundance of Treg cells among donor 
cells several days after transfer. 
 
 
 
Figure 10 - DO11.10+ CD4 SP cells give rise to Treg after intrathymic injection into 
AIRE-HCO recipient mice (A) CD4 SP thymocytes cells from CD45.1 DO11.10 Rago/o 
Foxp3-gfp mice were i.t. transferred into AIRE-HCO mice and analyzed for Foxp3-gfp and 
CD25 expression at the indicated time points after injection. Numbers indicate the frequency 
of cells within the respective quadrants. (B) Kinetics of intrathymic Treg development. The 
diagram depicts the percentage of Foxp3+ cells (left) or absolute numbers of total donor cells 
(right) that were recovered at the indicated time points after i.t. injection. 
 
The phenotypic heterogeneity of the progeny of CD4 SP donor cells injected into 
AIRE-HA recipients was strikingly reminiscent of the subsets of TCR-HA+ CD4 SP 
cells in the steady state TCR-HA × AIRE-HA thymus (Compare Fig 5 A). Moreover, 
the emerging CD25−Foxp3−, CD25+Foxp3− and CD25+Foxp3+ cells also seemed to 
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recapitulate the proliferative behavior of steady state PTR1, PTR2 and CD25+Foxp3+ 
subsets as revealed earlier using Ki67 staining (compare Figure 7 A). 
Taken together, these data demonstrate that upon “acute” exposure to the AIRE-HA 
intrathymic environment, antigen inexperienced TCR-HA+ CD4 SP cells can assume 
three different fates: Deletion, Treg conversion or proliferative expansion. 
 
5.4. Progressive maturation of CD4 SP thymocytes decreases their 
competence for Treg differentiation in vivo 
 
It is possible that the heterogeneous fate of a monoclonal cohort of SP thymocytes 
when injected into an antigen expressing host-thymus was at least in part caused by 
cell extrinsic factors such as cognate antigen recognition in distinct 
microenvironments. However, intrinsic heterogeneity within the starting population 
may also modulate the outcome of intrathymic antigen encounter. For example, it is 
well established that immature and mature CD4 SP cells display a differential 
susceptibility to negative selection (104), and we reasoned that the maturation stage 
of CD4 SP cells may similarly influence the efficacy with which these cells enter the 
Treg lineage. 
Progressive maturation of CD4 SP cells is characterized by a loss of CD69 
expression and upregulation of CD62L expression. Accordingly, CD4 SP cells of 
TCR-HA Rag2o/o Foxp3gfp mice segregated into CD69+(CD62L-) and 
CD69−(CD62L+) subsets, and the levels of CD24 correlated with those of CD69 in the 
expected manner (Figure 11 A and data not shown).  
When CD4 SP cells were fractionated on the basis of CD69 and CD62L expression 
and injected i.t. into AIRE-HA recipients, Treg cells emerged at a higher frequency 
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among the progeny of CD69+ “immature” cells (Figure 11 B). Along the same line, 
recovery of donor cells upon i.t. injection of CD4+CD8+ DP cells from TCR-HA 
Rag2o/o Foxp3gfp mice into AIRE-HA thymi was negligible, indicating efficient 
deletion in this setting, whereas upon i.t. injection of peripheral TCR-HA+ CD4 T cells 
only a low number of cells was deviated into the Treg lineage.  
 
 
 
 
Figure 11 - The maturation stage of CD4 SP cells determines the efficiency of Treg 
conversion in vivo. (A) Gated TCR-HA Rag2o/o CD4 SP thymocytes (left) can be subdivided 
into immature (CD69+CD62L–) and mature (CD69–CD62L+) cells (right). Numbers indicate 
the percentage of cells in the respective gates. (B) Intrathymic transfer of thymocyte 
subpopulations and peripheral T cells. DP, CD69+CD62L– CD4 SP, CD69–CD62L+ CD4 SP, 
and peripheral CD4+ cells from TCR-HA Rago/o Foxp3-gfp mice (CD45.1) were sorted and 
mixed with a PKH26 labeled reference population of total CD4 SP cells (CD45.1) at a ratio of 
1 : 2.6 prior to intrathymic transfer into AIRE-HA recipients. After five days, the recovery of 
the different tester populations was determined as the ratio of the respective cells to 
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reference cells among donor cells (CD45.1+) (left). The right diagram shows the percentage 
of Foxp3-gfp+ cells among tester cells (n.d. = not detectable). Data are representative of two 
independent experiments with n = 3. 
 
Taken together, these findings suggest a sliding scale of responsiveness in the CD4 
T cell lineage with regard to the interpretation of cognate antigen encounter, with a 
predisposition of DP and presumably very early CD4 SP cells to undergo apoptosis, 
merging into a phase of susceptibility to Treg conversion that ultimately gives way to a 
mature phenotype characterized by a strong propensity to proliferate. 
 
5.5. The role of mTEC in Treg differentiation in vivo  
 
We had shown earlier that in the TCR-HA × AIRE-HA system efficient induction of 
Treg was independent of antigen transfer and cross-presentation by DC, indicating 
that mTEC served a dual function as antigen-expressing and antigen-presenting cells 
(155). To further explore mechanistic commonalities between the steady state 
induction of Treg in the TCR-HA × AIRE-HA model with the adoptive transfer system 
used here, we next addressed the contribution of hematopoietic versus thymic 
epithelial cells as APC. To this end, CD4 SP cells from TCR-HA Rag2o/o Foxp3gfp 
mice were adoptively transferred into the thymus of mice that carried the matching 
restriction element (I-Ed) on TEC, but were either sufficient or deficient in their ability 
to present the cognate antigen on hematopoietic cells. Recipient animals were 
generated by lethal irradiation of F1 H-2b/d AIRE-HA mice followed by reconstitution 
with H-2d/d or H-2b/b bone marrow cells (Figure 12 A).  
In F1 AIRE-HAbm H-2b/b recipient animals, i.e. in the absence of the restriction element 
on hematopoietic cells, the induction of Treg cells was similarly, if not more, efficient 
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as compared to hosts that expressed I-Ed also on hematopoietic APC (F1 AIRE-HAbm 
H-2d/d) (Figure 12 B). Thus, cross-presentation of mTEC derived antigen by DC was 
dispensable, suggesting mTEC as the APC-type that co-ordinates the conversion of 
CD4 SP cells into Treg cells in these settings. 
 
 
 
 
Figure 12 - Antigen presentation by hematopoietic cells is dispensable for Treg 
induction upon i.t. injection (A) Generation of bone marrow chimaeric recipient 
mice. F1 H-2b/d AIRE-HA mice were lethally irradiated and reconstituted with either H-
2d/d or H-2b/b bone marrow to generate F1 AIRE-HAbm H-2d/d or F1 AIRE-HAbm H-2b/b 
recipients, respectively. Six weeks later mice were injected with TCR-HA+ CD4 SP 
thymocytes (CD45.1). (B) Injected cells were analyzed for expression of Foxp3-gfp 
and CD25 five days after transfer. Numbers indicate the percentage of Foxp3-gfp+ 
cells. Two to three mice per group were injected and one representative plot per 
group is shown. 
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5.6. Deviation of CD4 SP cells into the Treg lineage in vitro does not require a 
dedicated thymic stromal APC 
 
Assessing the efficiency of Treg induction in vivo upon i.t. transfer is complicated by 
the fact that eventually asynchronous thymic egress of cells either committing into 
the Treg lineage or not can only insufficiently be controlled for. Thus, preferential 
retention or egress of a particular subset of cells may possibly complicate the correct 
interpretation of the actual efficacy or timing of Treg induction. We considered the use 
of FTY720 as an inhibitor of thymic emigration, however, there is accumulating 
evidence that FTY720 itself may modulate the function or even promote the de novo 
induction of Treg cells (167-169). We therefore sought to establish an analogous in 
vitro system that on the one hand would eliminate these migration-related caveats, 
and on the other hand would reduce the complexity of cellular interaction partners. 
We first sought to confirm that the recognition of endogenously expressed cognate 
antigen on mTEC was sufficient for Treg conversion of CD4 SP cells in a minimal in 
vitro system. To this end, purified mTEC from AIRE-HA mice were co-cultured with 
naïve CD4 SP cells from TCR-HA Rag2o/o Foxp3gfp mice. After five days, cells were 
harvested and analyzed, revealing efficient induction of Treg cells (ranging from 20% 
to 25% between experimental replicates, data not shown). Kinetic analyses indicated 
that the sequential emergence of Foxp3−CD25+ and Foxp3+CD25+ cells by and large 
reproduced the in vivo results (data not shown). Similar results were obtained using 
mTEC from AIRE-HCO mice and DO11.10 CD4 SP cells (data not shown). 
In the Th1/Th2 paradigm, it is well established that multiple factors such as cytokines, 
APC-type and antigen dose to some extent influence the fate of mature helper T 
cells. We hypothesized that the avidity of cognate interactions in conjunction with 
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qualitative features of particular thymic stromal cells may in a similar way impinge on 
decision making by developing thymocytes. So far, our in vivo studies neither allowed 
delineating the relationship between antigen dose and efficiency of Treg induction, nor 
did they exclude that stromal cells other than mTEC, e.g. thymic DC, may principally 
be capable of converting CD4 SP cells.  
 
 
Figure 13 - Induction of Treg cells by different thymic stromal APC in vitro. (A) TCR-HA 
Rag2o/o CD4 SP thymocytes were co-cultured with mTEC, thymic cDC and thymic pDC in the 
presence of increasing amounts of HA peptide. After five days T cells were analyzed for 
CD25 and Foxp3-gfp expression. The bar diagram shows the percentage of Foxp3+ cells 
recovered. One representative plot for mTEC, cDC and pDC induced Treg differentiation at 
their respective optimal antigen dose is shown. (B) Separation of thymic DC into pDC, Sirpα+ 
cDC, and Sirpα¯ cDC subpopulations. The histogram shows a Sirpα+ staining of gated 
CD11chigh thymic dendritic cells (C) Sirpα+ and Sirpα¯ cDC were co-cultured with TCR-HA+ 
CD4 SP cells in the presence of increasing amounts of HA peptide. The diagram shows the 
percentage of Foxp3+ cells recovered after 5 days.  
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To address the ability of different thymic stromal APC to induce Treg, TCR-HA+ CD4 
SP cells were co-cultured with mTEC, CD11chighCD45RA- conventional DC (cDC) 
and CD11cintCD45RA+ plasmacytoid DC (pDC) in the presence of titrated amounts of 
HA peptide. Remarkbly, this revealed that both mTEC and thymic DC populations 
supported the differentiation of Treg cells from CD4 SP in vitro, though with markedly 
different dose response curves (Figure 13 A).  
Thus, Treg differentiation induced by mTEC operated most efficiently at peptide 
concentrations that exceeded the respective optimum of both subsets of cDC by 
about two orders of magnitude. The optimal peptide concentration for pDC-mediated 
Treg induction was in between that of cDC and mTEC. Conventional thymic DC have 
been further subdivided into two populations, based upon expression of SIRPα. 
Sirpα- and Sirpα+ cDC have been shown to arise from different precursors, with the 
former arising from intrathymic progenitors and the latter considered to be a 
migratory population of DC arising extrathymically (170). Since these populations 
were recently suggested to differ in their potency to induce Treg we co-cultured CD4 
SP cells with sorted subpopulations of cDC (Figure 13 B) and titrated amounts of HA 
peptide. Both populations readily induced Treg differentiation with Sirpα- cDC 
consistently showing a higher potency in doing so. Dose optima were similar for both 
cDC populations (Figure 13 C). 
 
5.7. Differential predisposition of immature and mature CD4 SP thymocytes 
for Treg differentiation in vitro 
 
In another series of in vitro experiments, we confirmed and extended our in vivo 
findings concerning the inverse correlation of T cell maturation and the propensity to 
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undergo Treg differentiation. The relative and absolute yield of Foxp3+CD25+ cells with 
mTEC or cDC at their respective peptide optimum was consistently higher with 
immature CD69+ CD4 SP responders as compared to mature CD69− cells (Figure 14 
A). Along these lines, conversion of peripheral CD4+ responders from TCR-HA 
Rag2o/o Foxp3-gfp mice was barely detectable. 
 
 
Figure 14 - T cell maturation impinges on the efficiency of Treg induction in vitro. (A) 
The indicated T cell subpopulations were co-cultured with mTEC or cDC at their respective 
optimal peptide concentrations. The diagrams show the percentage (upper) or total number 
(lower) of Foxp3+ cells recovered after 5 days. (B) Inverse correlation of Treg induction 
efficiency and proliferation. CFSE labeled mature and immature CD4 SP cells from TCR-HA 
Rag2o/o mice were co-cultured with mTEC or cDC at their respective optimal peptide 
concentration and analyzed for Foxp3 expression and CFSE dilution after 5 days.  
 
Whereas the predisposition for Treg differentiation decreased with maturation of CD4 
SP cells, the propensity to proliferate upon antigenic stimulation exhibited an inverse 
behavior (Figure 14 B). Thus, when CFSE-labeled CD69+ or CD69− CD4 SP 
responder cells from TCR-HA Rag2o/o mice were co-cultured with either mTEC or 
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cDC at the respective optimal peptide concentration, the progeny of mature cells 
went through a considerably higher number of cell cycles. This was seen with both 
types of APCs and irrespective of whether the T cells had acquired a Foxp3+ 
phenotype or not (Figure 14 B). 
Together, these findings not only confirmed the T cell intrinsic developmental control 
of Treg development in an in vitro system of minimized complexity, but also revealed a 
surprising degree of redundancy among thymic stromal APCs in their principle 
capacity to support Treg differentiation, given that APC-specific optimal doses of 
agonist ligand are provided. 
 
5.8. Treg differentiation of TCR transgenic and polyclonal thymocytes in an 
APC-free system 
 
The largely redundant capacity of thymic APCs to orchestrate Treg development may 
indicate that all of these cells similarly provide known and unknown critical co-
stimulatory ligands or factors. Alternatively, Treg differentiation of thymocytes may 
proceed with minimal requirements beyond a matching TCR stimulus and cytokine 
signaling. We therefore assessed Treg differentiation in an APC-free system in which 
only signal 1 in the form of plate-bound anti-CD3 together with exogenous IL-2 would 
be present. Of several conditions tested (data not shown), anti-CD3 coated at 
10µg/ml was found to induce the differentiation of significant numbers of 
CD25+Foxp3+ cells within TCR-HA Rag2o/o Foxp3-gfp thymocytes (Figure 15 A). 
Importantly, this APC-free system again recapitulated the gradual loss of 
competence for Treg differentiation with progressive maturation within the CD4 
lineage (Figure 14 A). Supporting the general relevance of our observations beyond 
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TCR transgenic systems, we observed an analogous behavior for polyclonal CD4 T 
cells of various developmental stages (Figure 15 B). 
 
Figure 15 - Treg induction in an APC-free system. 
(A) Immature and mature CD4 SP T cells from TCR-
HA rago/o Foxp3-gfp mice were sorted and cultured in 
the presence of plate-bound anti-CD3. Cells were 
analyzed for CD25 and Foxp3-gfp expression after 3 
days. The percentage (left) and absolute numbers 
(right) of Foxp3+ cells is depicted. (B) Immature 
(CD69+CD62L–) and mature (CD69–CD62L+) 
polyclonal CD25–Foxp3– CD4 SP cells were sorted 
from Foxp3-gfp mice and cultured and analyzed as 
in A. 
 
5.9. Treg conversion of CD4 SP thymocytes requires TGFβ in vitro 
 
Recent studies have cast doubt onto the commonly held view that the generation of 
“natural” Treg in the thymus and the induction of “adaptive” Treg from peripheral CD4+ 
T cells follow fundamentally different rules regarding the requirement for TGFβ-
signaling (137). To examine the contribution of TGFβ-signaling in our in vitro assays, 
we made use of both a monoclonal TGFβ-neutralizing antibody and the 
pharmacological inhibitor SB431542, which selectively inhibits activin-like kinase 
receptors. We first established the optimal conditions of TGFβ-inhibition that 
efficiently abrogated Treg generation using splenic APC and saturating doses of 
exogenous TGFβ-1 (Figure 16 A and B). Using this mode of TGFβ-inhibition, we 
found a strong reduction of both mTEC- and thymic cDC-mediated Treg conversion 
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(Figures 16 C and 16 D). Of note, the diminution of Treg conversion, although 
profound, was not complete but rather shifted the dose response curve towards lower 
antigen doses, in particular with mTEC. 
 
 
 
Figure 16 - Inhibition of Treg induction by TGFβ-neutralizing antibody or the 
pharmacological inhibitor SB431542. (A) Naïve TCR-HA T cells were co-cultured for five 
days with splenic APC and 5µg/ml HA-peptide in the presence of 0.1 or 2.5 ng/ml TGFβ-1 
and increasing concentrations of a TGFβ-neutralizing antibody. (B) Naïve TCR-HA T cells 
were co-cultured with splenic APC and 5µg/ml HA-peptide in the presence of 0.1 or 1 ng/ml 
rhTGFβ-1 and increasing concentrations of SB431542. The percentage of Foxp3+ cells 
versus the concentration of either TGFβ-neutralizing antibody (A) or SB431542 (B) is shown. 
Data are representative of two independent experiments.(C, D) Effect of TGFβ-inhibition on 
Treg differentiation in vitro. TCR-HA+ CD4 SP cells were co-cultured with WT mTEC or WT 
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thymic cDC in the presence of the indicated concentrations of HA peptide with or without 
inhibition of TGFβ-signaling (TGFβ-neutralizing mAb plus the inhibitor SB431542 at 
concentrations of 10µg/ml and 3µM, respectively). T cells were analyzed for Foxp3-gfp and 
CD25 expression after five days. The percentage of Foxp3-gfp+ cells induced by mTEC (C) 
or thymic cDC (D) in the presence or absence of TGFβ-inhibition is shown. Data are 
representative of at least three independent experiments. 
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6. Discussion 
 
The two-step model of Treg development subdivides Treg development into a first 
“instructive” phase requiring TCR engagement and a second 
“maturation/consolidation” phase relying solely on cytokine signals (165). The 
heterogeneity and developmental potential of TCR-HA+ CD4 SP cells in the TCR-HA 
× AIRE-HA thymus was strikingly reminiscent of pre-Foxp3 stages of polyclonal Treg 
development. Thus, a fraction of TCR-HA+CD25−GITR+Foxp3− and TCR-
HA+CD25+GITR+Foxp3− thymocytes differentiated into TCR-HA+CD25+ GITR+Foxp3+ 
cells when transferred into a WT thymus, i.e. in the absence of further encounter of 
cognate antigen, emphasizing that this TCR transgenic model faithfully recapitulates 
intrathymic “natural” Treg development. 
Consistent with a confinement of Foxp3 function to late stage Treg differentiation (120-
122), we found that the characteristic hypomethylated state of the TSDR within the 
Foxp3 locus is established only rather late during intrathymic Treg development. 
Expression of Foxp3 mRNA preceded loss of methyl marks, indicating that these 
epigenetic modifications at the Foxp3 locus are the consequence rather than the 
cause of commitment to the Treg lineage. Pre-Foxp3 stages of steady state Treg 
differentiation were characterized by low but significant levels of cell-cycling. 
Similarly, essentially all Foxp3+ cells emerging upon i.t. injection of CD4 SP cells had 
gone through a low number of cell cycles. By contrast, excessive cycling appeared 
incompatible with Treg differentiation in vivo. This scenario bears some resemblance 
to the inverse correlation of cell division and rate of Treg conversion of peripheral 
CD4+ T cells by suboptimal antigen doses (171) and to the role of cell-cycling during 
early thymocyte development, where at least one cell-cycle is thought to be 
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necessary for the DN-DP transition (172). It remains to be established whether 
changes in the methylation status of the TSDR are brought about by active 
demethylation or result from a lack of de novo methylation during cell division. 
It is controversial whether the presumed instructive TCR stimulus that initiates Treg 
differentiation needs to be delivered at a distinct stage of thymocyte development, 
e.g. the CD4+CD8+ DP or the CD4 SP stage (87, 146, 155-158). Here, using the 
intrathymic transfer of truly “antigen-inexperienced” CD4 SP cells we found that Treg 
differentiation can efficiently be initiated at the CD4 SP stage. The nature and timing 
of phenotypic changes that accompanied Treg differentiation ensuing from i.t. injection 
of TCR-HA+ CD4 SP cells correlated well with the heterogeneity and developmental 
potential of CD4 SP cells present in the steady-state TCR-HA × AIRE-HA thymus. 
Thus, intrathymic Treg induction can occur in a manner that is fully dissociated from 
positive selection and CD4/CD8 lineage commitment. 
Thymectomy of 3-day-old mice leads to severe autoimmunity which has been 
attributed to a lack of Treg cells (reviewed in (111)). The appearance of Foxp3+ cells 
during ontogeny is delayed as compared to “mainstream” T cells. It was suggested 
that the neonatal paucity of Treg is caused by the transient absence of an as yet 
undefined medullary niche facilitating Treg induction (87). The kinetics of Treg induction 
from CD4 SP cells reported here offer an alternative explanation. Thus, acquisition of 
the Foxp3+ mature Treg phenotype occurs only about three days after the instructive 
TCR signal. This indicates that even if all requirements for Treg induction were met 
once the ontogenetically earliest wave of CD4 SP cells enters the medulla during the 
perinatal phase, emergence of “mature” Treg cells would not be expected before 
another three days. 
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Initiation of Treg differentiation at the CD4 SP stage implies a critical role of medullary 
APC, i.e. mTEC and/or DC. We found that Treg induction in the adoptive transfer 
system was independent of presentation of the cognate antigen by thymic DC, 
consistent with our earlier observations in the steady state (155). Moreover ex vivo 
isolated mTEC supported the differentiation of Treg from naïve CD4 SP cells in vitro. 
However, the comparison of thymic cDC, pDC and mTEC in the in vitro system 
revealed that antigen presentation by either cell type is compatible with Treg induction, 
provided that the “optimal” antigen dose is available. Intriguingly, although we found 
earlier that mTEC and thymic DC deliver a similarly strong “signal one” at a given 
concentration of exogenously provided peptide as determined with a co-stimulation 
independent T hybridoma (155), the optimal concentration of antigen for Treg 
induction in vitro was about two orders of magnitude higher for mTEC as compared 
to cDC. This discrepancy indicates that TCR-pMHC avidity is not the sole 
determinant of Treg induction, and implies that a combination of quantitative and 
qualitative aspects of antigen recognition orchestrates Treg differentiation. Irrespective 
of the latter considerations, our findings offer an explanation for why neither lack of 
MHCII on hematopoietic cells nor defective development of mTEC were reported to 
promote obvious perturbations in the polyclonal Treg pool (20, 156), and may 
reconcile apparently conflicting results concerning the involvement of particular 
thymic stromal cell types in Treg development (155, 163). We suggest that the 
similarly large thymic Treg population in the absence of antigen presentation on either 
mTEC or thymic DC (20, 147, 155, 156) is a reflection of homeostatic mechanisms 
acting downstream of bona fide differentiation processes, rather than an indication of 
true redundancy at the level of TCR specificities. With the help of large scale 
sequencing and fixed TCRβ chains, this may be a testable hypothesis (119, 173). 
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Is the emergence of rapidly cycling CD25+ cells that do not upregulate Foxp3 an 
artifact of intrathymic injection of CD4 SP cells? Studying polyclonal thymocytes, Lio 
et al. found that less than half of the CD4 SP CD25+Foxp3− thymocytes differentiate 
into CD25+Foxp3+ cells upon injection into a WT thymus (165). While the presence of 
heterogeneous specificities among polyclonal CD25+Foxp3− cells might explain this 
observation, we prefer an alternative interpretation. Thus, even when we i.t. injected 
a monoclonal cohort of T cells that was purified to phenotypic homogeneity (e.g. CD4 
SP CD69+CD24hi) into an environment that was principally permissive for Treg 
induction, the progeny of these cells segregated into CD25+Foxp3− and 
CD25+Foxp3+ cells. We propose that these rapidly cycling CD25+Foxp3− cells are the 
equivalent of a large fraction of the polyclonal CD25+Foxp3− thymocytes. Indeed, 
polyclonal CD25+Foxp3− cells also contain a fraction of cycling cells (our unpublished 
observation). A subset of these cells may engage in abortive proliferation, as 
evidenced by the increased frequency of Annexin-V+ cells. However, it is also 
tempting to speculate that at least some of these CD25+Foxp3− cells produce 
cytokines, most likely IL-2, to facilitate terminal differentiation of Treg cells in the 
thymus and/or are direct precursors of peripheral CD25loFoxp3− cells, which have 
been implicated in the production of IL-2 necessary for Treg homeostasis (174). 
Treg are commonly subdivided into so called natural Treg, which arise during 
intrathymic selection, and adaptive Treg, which are products of peripheral conversion 
(175). This distinction implies fundamentally different principles underlying the 
emergence of either class of Treg. For example, TGFβ was commonly believed to be 
dispensable for intrathymic generation of a diverse Treg repertoire (176), but essential 
for the conversion of mature CD4+ T cells (124, 177, 178). However, this concept has 
recently been challenged and TGFβ may indeed serve a more universal role in the 
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induction of both subgroups of Treg (137). The results reported here cast further doubt 
onto a formal distinction between natural and adaptive Treg with respect to 
mechanistic aspects of their differentiation. Of note, our data do not exclude that 
there is a low avidity window in which Treg deviation of thymic and peripheral cells 
might occur in a TGFβ independent manner (179). 
The question remains: What discriminates whether a developing CD4 T cell is 
subject to clonal deletion rather than deviation into the Treg lineage? There is growing 
evidence that the thymic medulla represents a mosaic of stromal niches in which self-
antigens, in particular so called “peripheral tissue antigens”, may not be 
homogeneously available (68, 180). As a consequence, serial contacts with thymic 
stromal cells may be required until an autoreactive CD4 SP thymocyte engages in a 
tolerogenic interaction with an APC presenting the respective self-antigen at 
appropriate levels. If and when during the four to five days residence time of CD4 SP 
cells in the medulla such a rendezvous occurs would be subject to stochastic 
fluctuations. It has been described more than a decade ago that during progressive 
maturation at the CD4 SP stage, thymocytes undergo a quite dramatic switch from 
“tolerance susceptibility” to “tolerance resistance”, whereby tolerance was used 
synonymously with clonal deletion at the time (104). How Treg induction fits into this 
scenario remains to be established. For example, it remains unclear at which 
developmental stage (pre- or post-positive selection) the principle capacity to branch 
off into the Treg lineage is acquired. Nonetheless, our data show that once 
established, this capacity persists well into the CD4 SP stage, yet gradually 
decreases during progressive maturation. Ultimately, “aged” peripheral CD4 T cells 
displayed a dramatically reduced propensity to differentiate into Treg when exposed to 
conditions that efficiently convert CD4 SP thymocytes. We propose that thymocytes 
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that escape negative selection, e.g. due to limited access to self-antigen presented 
by rare stromal APC, immediately after losing the susceptibility to be deleted enter a 
phase of exquisite “susceptibility” to being deviated into the Treg lineage. In other 
words, TCR triggering with the exact same avidity and in the exact same context may 
be integrated in different ways by CD4 T cells at particular developmental stages. We 
therefore argue that decision making by individual autoreactive thymocytes cannot 
sufficiently be explained solely on the basis of an avidity model, not even when 
limited cytokine resources are incorporated (164). Instead, we propose that any 
model of Treg development also needs to consider the somewhat underexplored 
aspect of developmental progression within the CD4 SP compartment and an 
ensuing sliding scale of responsiveness (see Figure 17). 
 
 
 
Figure 17 – Integration of TCR-triggering at distinct T cell developmental stages. 
Strong TCR-triggering results in fundamentally different outcomes in T cells of 
different maturity. While DP cells are efficiently deleted, maturation coincides with a 
reduction of susceptibility to undergo apoptosis that is virtually lost or has to be 
induced by different mechanisms in mature CD4 SP and peripheral cells. The loss of 
susceptibility to undergo apoptosis is followed by the gradual acquisition of strong 
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proliferative potential. In between these phases of preferential induction of apoptosis 
and the induction of proliferation cells pass through a stage of exquisite receptivity to 
Treg induction. Most likely there are overlaps between phases of recessive or 
dominant tolerance induction with deletion and Treg induction happening in parallel in 
populations of thymocytes as defined above. The lack of proliferative potential might 
favor Treg induction as opposed to proliferation. The molecular basis for this 
difference is currently unknown, however. 
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7. Material and Methods 
 
7.1. Animals 
Mice were bred in the animal facility of the Research Institute of Molecular Pathology 
or in the animal facility of the Institute for Immunology of the LMU Munich in 
individually ventilated cages. TCR-HA, AIRE-HA, AIRE-HCO and DO11.10 mice 
have been described (155, 181, 182). Foxp3gfp knock-in mice were kindly provided by 
Dr. Alexander Rudensky (88). Mice were backcrossed to BALB/c for at least five 
generations. All animal studies were approved by local authorities. 
 
7.2. Antibodies and flow cytometry 
Biotin-conjugated monoclonal antibodies (mAbs) to CD8 (53-6.7), CD24 (30-F1), 
GITR (DTA-1), Qa-2 (1-1-2), CD44 (IM7), CD62L (MEL-14), CD45RA (14.8), and 
CD69 (H1.2F3), PE-conjugated streptavidin, Annexin-V, and mAbs to Ki67 (B56), 
Qa-2 (1-1-2), PD-1 (J43), and GITR (DTA-1), CyChrome-conjugated mAb to CD8 
(53-6.7), APC-conjugated CD45.1 (A20), and CD172a/Sirp α (P84), APC-Cy7 
conjugated mAb to CD4 (GK1.5), and PE-Cy7 conjugated Streptavidin and mAb to 
CD25 (PC61) were obtained from Becton Dickinson. The mAbs to TCR-HA (6.5) and 
DO11.10 (KJ26) were purified and conjugated to Alexa647, PE, or biotin in our 
labaratory. Anti–mouse TGF-ß1/2 (1D11.16.8) was purified in our lab. Surface 
staining was done according to standard procedures at a density of 1 × 106 to 4 × 106 
cells per 50µl, and volumes were scaled up accordingly. Ki67 and Annexin-V 
stainings were done according to the manufacturer’s instructions. A FACSCanto 
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(Becton Dickinson) with FACSDiva software (Beckton Dickinson) was used for data 
acquisition, data analysis was done using FlowJo software (Tree Star Inc.). 
 
7.3. Genotyping  
For genotyping, mouse tail pieces were digested in 50 μl of tail buffer for 6 hours at 
55°C, followed by Proteinase K inactivation at 95°C for 5 minutes. The following 
solutions/conditions were used for the tail digest: 
 
Gitocher buffer (10x) 
670mM Tris pH 8.8  
166mM ammonium sulfate  
65mM MgCl2  
0.1% Gelatin  
 
Digestion reaction 
3mm mouse tail 
3µl Proteinase K (10mg/ml stock) 
2.5µl Triton (10% Stock) 
5µl Gitocher Buffer (10x) 
0.5µl β-Mercapto-ethanol  
39µl H2O 
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1 μl of the 50µl-digestion reaction mixture was used as a template for the genotyping-
PCR reaction. The following buffers/solutions and conditions were used for the 
genotyping-PCR reactions: 
 
PCR Buffer (5x) 
250mM KCl  
50mM Tris pH 8.3  
43% Glycerol  
7.5mM MgCl2  
2mM Cresol Red  
 
PCR reaction 
1µl template 
250nM primers (final)  
200µM dNTP (final) 
PCR Buffer (1x final) 
Taq Polymerase 
Ad 30µl with H2O 
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PCR protocol 
Temperature (°C) duration 
(s) 
cycles 
94 180  
94 45 2 
60 45  
72 60  
94 45 2 
58 45  
72 60  
94 45 2 
56 45  
72 60  
94 45 30 
54 45  
72 60  
72 300  
 
Primers used for genotyping 
 sequence  amplicon 
fwd ACAAGGTGGCAGTAACAGGA  TCR-HA ~800bp 
rev ACAGTCAGTCTGGTTCCTGA    
fwd GCAACATGTTATCCAGTAGCCGGT RAG2 ~600bp WT 
rev TTGGGAGGACACTCACTTGCCAGT  ~1000bp Rag2 ko 
int GTATGCAGCCGCCGCATTGCATCA   
fwd CAGGAGGGATCCAGTGCCAGC DO11.10 ~290bp 
rev TGGCTCTACAGTGAGTTTGGT   
fwd ACAGCCACTCCTGTCTTTGC  AIRE-HA ~1300bp 
rev CTCCGTCAGCCATAGCAAATTTCT    
fwd ACAGCCACTCCTGTCTTTGC  AIRE-HCO ~1200bp 
rev GAATTGTTCGCATGGTAGCC    
fwd AGACAGACCAGAGGTGTAGT Foxp3gfp ~200bp WT  
rev TCCTGGGGATGGGCCAAGGGCCAAGG  ~800bp Foxpgfp 
fwd AGACAGACCAGAGGTGTAGT Foxp3gfp ~200bp WT  
rev TCCTGGGGATGGGCCAAGGGCCAAGG  ~800bp Foxpgfp 
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7.4. Preparation of thymic stroma  
Thymi from 3-week-old mice were cut into small pieces and were digested at 37°C in 
IMDM containing 0.2 mg/ml of collagenase (Roche), 0.2 mg/ml of dispase I (Roche), 
2% (vol/vol) FCS, 25 mM HEPES, pH 7.2, and 25 µg/ml of DNase I. Cells were re-
suspended every 5 min.  After 25 min fresh medium was added and cells were 
digested for another 15 min, followed by the addition of EDTA (5mM final 
concentration) and incubation for 5 min. Cells were then washed and re-suspended 
in Percoll (ρ, 1.115; GE Healthcare). A discontinuous gradient was then generated by 
the addition of a layer of Percoll (ρ, 1.055) followed by a layer of IMDM on top of this 
cell suspension. Gradients were spun for 30 min at 1,350g at 4°C. To avoid 
disturbance of the gradient before and after centrifugation, the acceleration of the 
centrifuge was reduced and the brakes were switched off. After centrifugation, low-
density cells were collected from the upper interface, washed and stained for cell 
sorting. Stromal cells were sorted according to CD45, Ly51, EpCAM, CD11c, 
CD45RA and Sirpα expression (mTEC = CD45-Ly51-EpCAM+ ; pDC = 
CD45+CD11cintCD45RA+ ; Sirpα+ cDC = CD45+CD11chighCD172a+ ; Sirpα- cDC = 
CD45+CD11chighCD172a-). The following buffers/solutions were used for the 
preparation of thymic stromal cells: 
 
Percoll gradient solutions 
 
100ml high densitiy percoll (ρ = 1.115g/ml): 
90ml Percoll (GE Healthcare, ρ = 1.134g/ml) 
10ml 10x PBS 
25mM HEPES pH 7.2 (final) 
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 low densitiy percoll (ρ = 1.055g/ml): 
20ml Percoll (GE Healthcare, ρ = 1.134g/ml) 
26ml 1x PBS 
25mM HEPES pH 7.2 (final) 
 
optional: 
low densitiy percoll (ρ = 1.045g/ml): 
20ml Percoll (GE Healthcare, ρ = 1.134g/ml) 
31.1ml 1x PBS 
25mM HEPES pH 7.2 (final) 
 
7.5. Purification of CD4 SP and CD4+ peripheral cells   
CD4 SP cells from TCR-HA Rag2o/oFoxp3gfp mice or subpopulations of TCR-HA × 
AIRE-HA Foxp3gfp mice were purified by staining of thymocyte cell suspensions with 
biotinylated- anti-CD8 antibody, followed incubation of cells with streptavidin 
Microbeads (Miltenyi Biotech) and depletion of CD8+ cells using LS-MACS columns 
(Miltenyi Biotech). 20µl of MACS Microbeads plus 180µl of MACS Buffer were 
routinely used for 108 cells. The CD8- fraction was stained for the indicated surface 
markers and cells were sorted using a FACSAria cell sorter (Beckon Dickinson). 
Naïve peripheral cells were obtained by staining of a pooled suspension of Spleen 
and lymph node (mesenteric, axillary, brachial, inginual, popliteal and cervical) cells 
with biotinylated anti-CD4 antibody, followed by incubation of cells with streptavidin 
Microbeads and enrichment of CD4+ cells using LS-MACS columns. The CD4+ 
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fraction was stained for the indicated surface markers and cells were sorted using a 
FACSAria cell sorter. 
 
7.6. Intrathymic transfer  
The indicated number of CD4 SP or peripheral cells was purified from donor mice 
(CD45.1) as described above, washed two times in PBS, re-suspended in PBS and 
intrathymically tranferred into one thymic lobe of congenic WT (CD45.2) or AIRE-HA 
(CD45.2) recipient mice using a Hamilton syringe. The cells were transferred in a 
volume of 3µl.At various time points after transfer mice were sacrificed, thymi were 
depleted of CD8+ cells as described above, stained for surface markers and analyzed 
by flow cytometry using a FACS Canto II (Becton Dickinson). 
 
7.7. In vitro differentiation assay 
For in vitro differentiation assays thymic stromal APC and T cells of various 
developmental stages were purified as described above. Sorted thymocytes or 
peripheral T cells (5 × 104) from TCR-HA Rag2o/oFoxp3gfp mice were co-cultured with 
sorted mTEC, thymic cDC (SIRPα+/-) or thymic pDC (1 × 104) of AIRE-HA or WT mice 
in the presence of the indicated amount of HA107-119 peptide (SVSSFERFEIFPK, 
recognized by the TCR-HA in the context of I-Ed) and 100 U/ml recombinant IL-2 
(Preprotech). TGFβ-signaling was inbibited by the addition of a TGFβ neutralizing 
antibody (1D11.16.8) and the activin receptor-like kinase inhibitor SB431542 (Sigma-
Aldrich) at a final concentration of 10µg/ml and 3µM, respectively. Analysis was 
carried out after three or five days.  
The following media was used for the differentiation assays: 
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7.8. Assessment of the methylation status of the TSDR 
 
To assess the methylation status of the TSDR within the first intron of the Foxp3 
gene the indicated populations of thymocytes of TCR-HA or TCR-HA × AIRE-HA 
were purified by FACS-sorting. Subsequently, genomic DNA was purified using the 
NucleoSpin Tissue XS Kit (Macherey-Nagel) according to the manufacturer’s 
instructions. DNA methylation analysis was performed by bisulfite sequencing as 
described previously (126). 
 
 
Media for primary T cell culture 
IMDM (Gibco)  
10% FCS  
0.292mg/ml L-Glutamin  
100U/ml Streptomycin 
100U/ml Penicilin  
50µM β-Mercaptoethanol 
 
7.9. Bone marrow chimaeras 
6 week old [BALB/c × BL/6] F1 (H-2b/d) AIRE-HA mice were lethally irradiated (2 × 450 
rad split dose) and were reconstituted with 5 × 106 T cell depleted C57BL/6 or 
BALB/c bone marrow cells by injection into the lateral tail vein immediately after the 
second irradiation. Intrathymic transfer was carried out 6 weeks after bone marrow 
reconstitution as described above. After five days injected thymi were analyzed both 
for chimaerims, by digesting a piece of the thymus and subsequent staining for I-Ed 
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or I-Ab expression on thymic DC, and for the phenotype of donor derived cells as 
described above. The chimaerism was routinely greater than 97%. 
 
7.10. RNA isolation and Real time PCR 
Total RNA was isolated using the High Pure RNA Isolation Kit (Roche) and 
transcribed into cDNA using the Superscript II Kit (Invitrogen) according to the 
manufacturer’s instructions. Quantification of Foxp3 mRNA levels was carried out 
using a MyiQ cycler (Biorad) and the iQ SYBR Green Supermix (Biorad). Expression 
levels were normalized to the expression levels of thymic Treg and calculated using 
the formula x = 2−∆∆Ct, where Ct represents the threshold cycle of a Foxp3 and ∆Ct 
represents the difference between Ct values of Foxp3 and the housekeeping gene β-
actin. ∆∆Ct is the difference between the ∆Ct values of the examined subpopulations 
and the ∆Ct value of thymic Treg. Intron-spanning primers for Foxp3 (fwd: 5’- 
GGCCCTTCTCCAGGACAGA -3’, rev: 5’- GCTGATCATGGCTGGGTTGT -3’) and β-
actin (fwd: 5’-GCCTTCCTTCTTGGGTAT -3’, rev: 5’- GGCATAGAGGTCTTTACGG -
3’) were tested by recording a melting curve and by agarose gelelektrophoresis. 
Program used for Real Time PCR 
Temperature (°C) duration 
(s) 
cycles 
94 300  
94 45 40 
56 45  
72 60  
72 60 final elongation 
 
Melting curves were recorded between 55 and 95°C (+0.5°C every 30s). 
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 7.11. Statistical analysis 
Statistical significance was assessed by the two-tailed Student`s t-test. 
 
7.12. Additional Buffers 
 
10 x PBS (10l) 
800g NaCl,  
20 g KCl 
115g Na2HPO4 · 2H2O 
20g KH2PO4, pH adjusted to 7.2 - 7.4  
 
FACS Buffer 
1 x PBS, 2% FCS, 1 mM EDTA 
 
MACS Buffer 
1 x PBS 0.5% BSA, 2mM EDTA (sterile filtered with 0.45µm filters) 
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